Postprocedural disorders of nervous system

G6_POSTOPNEURO

nervous system disease: A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G97 Hospital discharge: ICD-9 — 3490\|9970 Cause of death: ICD-10 — G97 Cause of death: ICD-9 — 3490\|9970 2 out of 7 registries used, show all original rules.	3100
4. Check minimum number of events None	3100
5. Include endpoints None	3100
6. Filter based on genotype QC (FinnGen only)	3100

Control definitions (FinnGen only)

Control exclude: G6_OTHNEU

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G90-G99
Name in latin: Morbositates systematis nervosi post interventiones non alibi classificatae

NAME	G6_POSTOPNEURO
CONTROL_EXCLUDE	G6_OTHNEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G97
HD_ICD_9	3490\|9970
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G97
COD_ICD_9	3490\|9970
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Postprocedural disorders of nervous system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17984	12561	5331
Only index persons	17409	12324	5085
Unadjusted period prevalence (%)
Whole population	0.30	0.36	0.15
Only index persons	0.38	0.45	0.19
Median age at first event (years)
Whole population	34.51	34.74	33.96
Only index persons	34.38	34.68	33.66

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3100	2403	697
Unadjusted period prevalence (%)	0.70	0.82	0.31
Median age at first event (years)	36.92	36.10	39.76

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2803: Matched controls
28029

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

+∞

323.0

320

TAB00

NOMESCO Finland

Lumbar puncture

20.4

323.0

725

471

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4503599627370496.0

323.0

2166

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

173.1

323.0

1039

R51.80

ICD-10 Finland

Headache

5.7

299.8

1050

2657

3490A

ICD-9 Finland

Other and unspecified disorders of the nervous system, Reaction to spinal or lumbar puncture

+∞

219.7

208

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

6.4

194.2

567

1070

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.5

147.9

484

1026

R20.2

ICD-10 Finland

Paraesthesia of skin

5.5

139.0

449

933

AA1AD

NOMESCO Finland

CT of head and brain

3.6

131.5

697

2338

N03AX12

ATC

gabapentin; oral

3.6

117.1

622

2068

N03AX16

ATC

pregabalin; oral

3.0

112.7

811

3353

G44.2

ICD-10 Finland

Tension-type headache

3.2

104.9

651

2410

N02AX02

ATC

tramadol; systemic, rectal

2.5

102.9

1233

6796

G35

ICD-10 Finland

Multiple sclerosis

10.9

99.9

198

194

ZXD05

NOMESCO Finland

Urgent procedure

2.4

96.0

1128

6090

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.3

92.9

379

984

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

91.2

1272

7427

R42

ICD-10 Finland

Dizziness and giddiness

2.9

91.0

656

2659

109

Kela drug reimbursment

Multiple sclerosis

11.2

83.1

162

153

G97.8

ICD-10 Finland

Other postprocedural disorders of nervous system

811.1

80.8

N06AX21

ATC

duloxetine; oral

3.2

78.7

470

1659

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.9

76.0

544

2167

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

28.4

75.9

104

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

10.7

70.5

140

137

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.5

69.3

261

620

N02BE01

ATC

paracetamol; systemic, rectal

2.5

68.9

2410

19986

A02BC02

ATC

pantoprazole; systemic

2.0

66.2

1743

12644

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.4

64.4

655

3151

G43.9

ICD-10 Finland

Migraine, unspecified

3.3

64.4

353

1160

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.3

64.2

253

627

M79.6

ICD-10 Finland

Pain in limb

2.1

64.2

1066

6419

H02AB06

ATC

prednisolone; systemic

2.0

64.0

1298

8465

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

9.9

63.4

131

138

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.3

63.3

347

1139

N06AA09

ATC

amitriptyline; systemic

3.3

61.2

334

1091

H46

ICD-10 Finland

Optic neuritis

12.0

59.9

112

A02BC05

ATC

esomeprazole; systemic

2.0

59.9

1129

7097

M03BX02

ATC

tizanidine; oral

1.9

58.3

1880

14356

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

57.8

876

5029

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.1

57.8

353

1249

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.4

57.3

306

982

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

56.3

1334

9064

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

53.2

1007

6265

M54.5

ICD-10 Finland

Low back pain

1.9

52.6

1027

6452

M25.5

ICD-10 Finland

Pain in joint

2.0

52.5

913

5490

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.9

52.3

347

1291

XA800

NOMESCO Finland

Neuropsychological investigation

4.7

51.0

184

416

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

10.8

50.4

N06AX11

ATC

mirtazapine; oral

1.9

50.0

916

5597

R51

ICD-10 Finland

Headache

3.4

50.0

262

826

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

49.6

627

3291

G97.9

ICD-10 Finland

Postprocedural disorder of nervous system, unspecified

496.4

49.5

G93.2

ICD-10 Finland

Benign intracranial hypertension

+∞

49.1

R03AC02

ATC

salbutamol; inhalant

1.8

48.8

1551

11422

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

48.6

960

6013

N06AX16

ATC

venlafaxine; oral

2.3

48.6

532

2613

M01AE02

ATC

naproxen; oral, rectal

1.8

48.3

1688

12799

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

48.3

724

4077

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

47.2

548

2762

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

9.8

47.1

102

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.4

46.4

449

2068

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

45.2

619

3347

G97.2

ICD-10 Finland

Intracranial hypotension following ventricular shunting

+∞

44.9

R53

ICD-10 Finland

Malaise and fatigue

2.1

44.6

591

3148

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.8

44.5

202

566

L03AX13

ATC

glatiramer acetate; parenteral

12.3

43.6

R06.0

ICD-10 Finland

Dyspnoea

2.1

43.4

586

3140

J01AA02

ATC

doxycycline; systemic

1.8

42.8

2104

17428

H53.1

ICD-10 Finland

Subjective visual disturbances

3.3

42.3

228

732

N03AX11

ATC

topiramate; oral

4.4

42.1

160

381

2309

FHL

Other measure in this category

218.2

42.0

A02BC03

ATC

lansoprazole; oral

1.9

41.8

734

4357

M01AB05

ATC

diclofenac; systemic, rectal

1.7

41.4

1841

14673

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.6

40.8

123

228

M01AH05

ATC

etoricoxib; oral

1.7

40.6

1626

12525

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

39.7

388

1788

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

5.7

39.5

118

216

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.9

39.4

133

280

L03AB07

ATC

interferon beta-1a; parenteral

10.8

38.1

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

37.8

782

4886

J01FA10

ATC

azithromycin; systemic

1.7

37.6

1795

14385

164

Kela drug reimbursment

Fingolimod

18.5

37.5

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.7

37.5

275

1082

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

37.2

523

2830

P01AB01

ATC

metronidazole; oral, rectal

1.7

37.1

1165

8278

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

192.5

36.9

J01DB01

ATC

cefalexin; oral

1.9

36.8

2298

19911

R01AD09

ATC

mometasone; nasal

1.7

36.4

1379

10310

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

36.0

568

3210

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

35.9

499

2685

A02BC01

ATC

omeprazole; systemic

1.9

35.8

679

4104

N05BA04

ATC

oxazepam; oral

1.9

35.7

689

4189

H53.2

ICD-10 Finland

Diplopia

5.0

35.6

117

240

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

67.5

35.0

N03AE01

ATC

clonazepam; systemic

3.2

34.9

196

645

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

34.8

766

4860

R52.2

ICD-10 Finland

Other chronic pain

4.1

34.6

139

349

M03BX01

ATC

baclofen; systemic

6.3

34.4

154

K30

ICD-10 Finland

Functional dyspepsia

2.4

34.3

328

1488

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

34.0

291

1247

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.9

33.9

144

381

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

33.8

451

2381

R50.9

ICD-10 Finland

Fever, unspecified

2.1

33.0

399

2016

SPAT1263

SPAT

Sampling

1.6

32.6

1180

8621

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

32.3

569

3335

C07AA05

ATC

propranolol; systemic

1.8

32.3

617

3717

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

6.0

31.9

154

M01AC06

ATC

meloxicam; systemic, rectal

1.7

31.8

909

6206

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

31.4

522

2991

J01MA02

ATC

ciprofloxacin; systemic

1.7

31.3

897

6128

J01FA06

ATC

roxithromycin; oral

1.6

31.2

1081

7778

UKC02

NOMESCO Finland

Cystoscopy

2.3

31.0

304

1391

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

30.7

501

2850

SPAT1301

SPAT

No procedures

1.7

30.6

790

5226

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

30.5

1021

7266

N06AB04

ATC

citalopram; systemic

1.8

30.2

597

3630

N05AH04

ATC

quetiapine; oral

1.9

30.2

508

2922

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.3

30.0

179

N05CF01

ATC

zopiclone; oral

1.7

29.6

715

4626

M54.2

ICD-10 Finland

Cervicalgia

2.5

29.5

240

997

G81.9

ICD-10 Finland

Hemiplegia, unspecified

9.4

29.4

M79.1

ICD-10 Finland

Myalgia

2.0

29.3

409

2189

XCK00

NOMESCO Finland

Perimetry

3.1

29.3

170

574

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

29.2

2067

17704

N86

ICPC

Multiple sclerosis

10.2

29.2

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.5

28.9

138

403

XKD00

NOMESCO Finland

Uroflowmetry

2.5

28.7

236

987

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

151.6

28.7

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

151.6

28.7

353

Kela drug reimbursment

Cladribine and fingolimod

16.1

28.5

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

28.5

463

2624

N05BA01

ATC

diazepam; systemic, rectal

2.1

28.5

336

1677

N01

ICPC

Headache

2.0

28.4

377

1976

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

28.2

1445

11368

A02BA02

ATC

ranitidine; systemic

1.9

28.0

431

2392

L04AA27

ATC

fingolimod; oral

17.2

27.9

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

27.7

673

4347

SPAT1153

SPAT

Removal of sutures

1.7

26.9

706

4660

N02AA05

ATC

oxycodone; systemic

2.3

26.9

262

1196

R55

ICD-10 Finland

Syncope and collapse

2.4

26.8

236

1023

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

26.8

798

5458

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

26.7

278

1310

R11

ICD-10 Finland

Nausea and vomiting

2.4

26.6

242

1068

S01EC01

ATC

acetazolamide; systemic

6.4

26.6

114

N03AX09

ATC

lamotrigine; oral

2.6

26.4

196

774

H47.1

ICD-10 Finland

Papilloedema, unspecified

15.6

26.4

UJF32

NOMESCO Finland

Coloscopy

1.8

26.4

540

3304

S06.0

ICD-10 Finland

Concussion

2.2

26.3

290

1403

G43.3

ICD-10 Finland

Complicated migraine

4.1

26.1

104

260

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

26.1

629

4045

C07AB07

ATC

bisoprolol; oral

1.6

26.1

822

5697

J01DA01

ATC

[U] cefalexin; systemic

1.5

25.9

1696

13999

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.8

25.9

173

641

N06AA10

ATC

nortriptyline; systemic

4.5

25.7

212

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

25.7

350

1848

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

25.6

1406

11137

R51.81

ICD-10 Finland

Facial pain NOS

4.2

25.6

100

246

J02AC01

ATC

fluconazole; systemic

1.5

25.6

1275

9878

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

25.5

321

1644

M79.7

ICD-10 Finland

Fibromyalgia

3.1

25.0

144

484

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

24.9

1432

11433

R03DC03

ATC

montelukast; oral

1.8

24.8

475

2839

Z00.0

ICD-10 Finland

General medical examination

1.8

24.5

470

2808

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

24.3

352

1903

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.5

24.3

201

841

M01AH01

ATC

celecoxib; oral (coxibs)

1.9

24.2

414

2378

R06AE07

ATC

cetirizine; oral

1.5

23.8

1267

9899

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

6.3

23.8

104

J01EA01

ATC

trimethoprim; systemic

1.6

23.8

673

4512

H02AB04

ATC

methylprednisolone; systemic

1.9

23.8

379

2122

R1250

NOMESCO Finland

Evaluation of functional capability

4.7

23.7

175

N02CC04

ATC

rizatriptan; oral

2.3

23.6

240

1116

M01AE01

ATC

ibuprofen; systemic, rectal

1.9

23.3

2560

23721

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.9

23.3

391

2229

R52.9

ICD-10 Finland

Pain, unspecified

2.3

23.1

230

1058

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

23.1

828

5895

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

11.8

23.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

23.0

255

1235

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

+∞

22.9

G91.1

ICD-10 Finland

Obstructive hydrocephalus

+∞

22.9

XKC03

NOMESCO Finland

Water cystometry

4.4

22.8

200

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.2

22.7

124

403

N06AB10

ATC

escitalopram; oral

1.6

22.5

662

4471

L04AX07

ATC

dimethyl fumarate; oral

9.2

22.5

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

22.5

317

1694

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

22.5

1534

12585

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

22.5

334

1822

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

22.4

502

3138

SPAT1310

SPAT

Counselling related to known health issue

1.6

22.4

808

5750

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

22.3

886

6452

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

9.0

22.3

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.6

22.3

173

J01CA04

ATC

amoxicillin; systemic

1.6

22.3

2303

20717

X58

ICD-10 Finland

Exposure to other specified factors

1.9

22.2

377

2157

G44.8

ICD-10 Finland

Other specified headache syndromes

5.1

22.2

143

WX110

NOMESCO Finland

Local anesthesy

1.5

22.1

1933

16688

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

22.1

1060

8054

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

22.1

182

762

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

21.7

759

5351

R03BA05

ATC

fluticasone; inhalant

1.7

21.6

507

3214

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

8.8

21.6

N03AF01

ATC

carbamazepine; oral, rectal

2.9

21.4

136

489

XKD06

NOMESCO Finland

Physiologic investigation of micturition

4.4

21.4

180

R01AD12

ATC

fluticasone furoate; nasal

1.5

21.2

920

6820

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.9

21.2

358

2043

J05AB01

ATC

aciclovir; systemic

1.6

21.1

573

3779

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

21.1

182

780

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

21.1

214

994

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.9

21.0

131

464

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

21.0

297

1586

G04BD12

ATC

mirabegron; oral

2.4

21.0

183

787

G45.3

ICD-10 Finland

Amaurosis fugax

28.3

20.9

H53.9

ICD-10 Finland

Visual disturbance, unspecified

3.7

20.8

259

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.4

20.8

179

765

N02CC07

ATC

frovatriptan; oral

2.3

20.7

193

860

N06BA07

ATC

modafinil; oral

11.0

20.6

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.5

20.6

164

675

N05CF02

ATC

zolpidem; oral

1.7

20.5

477

3010

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

20.5

466

2920

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.2

20.4

111

360

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.6

20.3

151

595

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

20.2

238

1182

M01AH02

ATC

rofecoxib; oral

2.0

20.1

264

1369

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

20.1

615

4185

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

20.0

260

1343

SPAT1260

SPAT

Consultation of another employee

1.7

20.0

428

2632

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

20.0

334

1897

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.2

19.9

222

1077

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.7

19.9

142

549

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

19.8

511

3317

M01AX17

ATC

nimesulide; oral

1.7

19.8

488

3130

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

6.7

19.7

J01CA08

ATC

pivmecillinam; oral

1.5

19.6

1161

9148

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

201.3

19.6

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.1

19.5

221

1077

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

19.5

436

2717

N03AG01

ATC

valproic acid; systemic, rectal

2.3

19.5

182

812

N29

ICPC

Neurological sympt/complt other

4.9

19.4

134

Z3231

NOMESCO Finland

Registered nurse

1.6

19.4

628

4327

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

19.4

674

4727

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

19.3

248

1273

G50.1

ICD-10 Finland

Atypical facial pain

4.1

19.3

185

A01

ICPC

Pain general/multiple sites

2.2

19.2

196

912

L03

ICPC

Low back symptom/complaint

1.6

19.2

618

4249

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

19.2

243

1241

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

19.2

735

5268

N04BB01

ATC

amantadine; oral

5.0

19.1

123

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

19.1

833

6151

G43.8

ICD-10 Finland

Other migraine

4.0

19.1

192

K07.60

ICD-10 Finland

Snapping jaw

2.2

18.9

189

873

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

18.9

292

1613

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

+∞

18.8

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

18.7

318

1812

G54.0

ICD-10 Finland

Brachial plexus disorders

3.0

18.7

108

365

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

18.6

269

1445

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

6.2

18.6

R20.0

ICD-10 Finland

Anaesthesia of skin

7.1

18.6

R07.3

ICD-10 Finland

Other chest pain

2.1

18.5

210

1026

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

6.3

18.5

J01FA09

ATC

clarithromycin; systemic

1.5

18.5

866

6483

L03AB08

ATC

interferon beta-1b; parenteral

11.9

18.3

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

18.2

210

1031

L04AA31

ATC

teriflunomide; oral

8.6

18.1

S18

ICPC

Laceration/cut

1.5

18.1

877

6604

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

18.1

265

1432

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

18.0

114

410

R03BA08

ATC

ciclesonide; inhalant

2.0

17.9

234

1211

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

17.8

421

2662

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.3

17.8

176

805

G44.0

ICD-10 Finland

Cluster headache syndrome

4.6

17.8

138

R33

ICD-10 Finland

Retention of urine

2.9

17.8

108

378

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

17.7

360

2175

N04BC05

ATC

pramipexole; oral

2.4

17.7

149

633

N30.0

ICD-10 Finland

Acute cystitis

1.8

17.6

348

2085

G50.0

ICD-10 Finland

Trigeminal neuralgia

4.2

17.5

159

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

17.5

826

6178

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.5

17.4

138

567

A06AD11

ATC

lactulose; oral

2.0

17.4

236

1239

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

17.4

1049

8238

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.6

17.4

130

516

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

6.7

17.4

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.9

17.3

106

373

D01

ICPC

Abdominal pain/cramps general

1.8

17.3

310

1798

R03BA01

ATC

beclometasone; inhalant

1.7

17.3

352

2128

N02CC05

ATC

almotriptan; oral

2.3

17.3

170

777

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

17.2

163

733

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

17.2

224

1155

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

17.2

111

405

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

17.1

301

1733

C08DA01

ATC

verapamil; systemic

3.2

17.1

281

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

17.1

308

1792

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

17.0

1470

12323

Z2445

NOMESCO Finland

Psychologist

2.4

16.9

143

606

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.5

16.9

131

531

H57.1

ICD-10 Finland

Ocular pain

2.8

16.8

111

409

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

16.8

319

1887

R21

ICPC

Throat symptom/complaint

1.5

16.8

653

4678

J05AB11

ATC

valaciclovir; oral

1.7

16.6

346

2103

C01CA24

ATC

epinephrine; parenteral

2.0

16.6

212

1087

C09CA06

ATC

candesartan; oral

1.6

16.6

463

3057

B01AB05

ATC

enoxaparin; parenteral

1.5

16.6

609

4297

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

16.6

510

3452

SPAT1254

SPAT

Administration of medicine

1.8

16.6

300

1743

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

171.0

16.5

N05BA12

ATC

alprazolam; oral

1.9

16.5

256

1413

R35

ICD-10 Finland

Polyuria

2.6

16.4

124

496

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.9

16.3

240

1300

N03AF02

ATC

oxcarbazepine; oral

3.0

16.3

336

R13

ICD-10 Finland

Dysphagia

2.4

16.3

143

620

N02CC06

ATC

eletriptan; oral

2.4

16.3

145

632

N02CC03

ATC

zolmitriptan; nasal, oral

2.0

16.3

209

1074

G04CA02

ATC

tamsulosin; oral

2.0

16.2

220

1155

W19

ICD-10 Finland

Unspecified fall

2.0

16.1

206

1058

SPAT1229

SPAT

Assessment of need for aid

2.4

16.1

138

590

TAB20

NOMESCO Finland

Epidural puncture

7.0

16.1

ZYC01

NOMESCO Finland

Remote contact by phone

2.4

16.1

138

591

M01AC01

ATC

piroxicam; systemic, rectal

1.8

16.1

269

1523

M54.3

ICD-10 Finland

Sciatica

2.3

16.0

154

698

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

16.0

918

7113

XA402

NOMESCO Finland

ENMG

3.2

16.0

262

J01FF01

ATC

clindamycin; systemic

1.5

16.0

641

4615

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

15.9

200

1018

R00.2

ICD-10 Finland

Palpitations

2.0

15.7

207

1075

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

15.7

160

747

G04BD08

ATC

solifenacin; oral

2.6

15.6

119

476

R06AX27

ATC

desloratadine; oral

1.4

15.6

823

6263

N06AB06

ATC

sertraline; oral

1.7

15.4

325

1982

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

15.4

385

2468

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

15.4

812

6177

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

3.1

15.4

281

H43.8

ICD-10 Finland

Other disorders of vitreous body

2.2

15.3

164

781

H03AA01

ATC

levothyroxine sodium; systemic

1.5

15.3

564

3979

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

15.2

860

6631

SPAT1240

SPAT

Therapeutic discussion

1.7

15.1

364

2307

R01AD08

ATC

fluticasone; nasal

1.4

15.1

783

5929

SPAT1216

SPAT

Assessment of functional ability

1.8

15.1

250

1411

L08

ICPC

Shoulder symptom/complaint

1.6

15.1

392

2535

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.7

15.0

323

1980

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.9

15.0

236

1309

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.7

14.9

104

396

J45

ICD-10 Finland

Asthma

1.8

14.9

256

1464

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

14.9

161

769

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

14.9

171

841

G47.3

ICD-10 Finland

Sleep apnoea

1.6

14.8

431

2869

M23.8

ICD-10 Finland

Other internal derangements of knee

2.5

14.8

119

494

ZXA00

NOMESCO Finland

Right side

1.5

14.8

496

3417

R03BA02

ATC

budesonide; inhalant

1.6

14.8

441

2957

M89.0

ICD-10 Finland

Algoneurodystrophy

5.4

14.8

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.7

14.8

340

2126

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

4.2

14.7

132

M54.1

ICD-10 Finland

Radiculopathy

2.6

14.7

107

419

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.9

14.7

241

1355

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

14.6

241

1358

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

14.6

175

873

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

+∞

14.6

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

14.6

110

441

N89

ICPC

Migraine

2.3

14.5

138

621

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

14.5

380

2463

A87.9

ICD-10 Finland

Viral meningitis, unspecified

5.0

14.4

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

6.4

14.4

Z71.8

ICD-10 Finland

Other specified counselling

1.5

14.4

639

4687

XQ800

NOMESCO Finland

Prick test

1.8

14.3

244

1392

A04

ICPC

Weakness/tiredness general

1.7

14.3

300

1829

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

14.3

1594

13767

A04AA01

ATC

ondansetron; systemic, rectal

2.2

14.3

147

688

J01FA15

ATC

telithromycin; oral

1.8

14.3

271

1599

N07XX09

ATC

[U] dimethyl fumarate; oral

9.1

14.2

XF404

NOMESCO Finland

Ambulatory ECG

2.0

14.1

174

880

Z3226

NOMESCO Finland

Physiotherapist

1.6

14.1

410

2731

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

14.1

122

526

ZXE00

NOMESCO Finland

One hour or less

1.4

14.1

996

7970

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

14.0

179

916

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

14.0

151

723

A01AB04

ATC

amphotericin B; local oral

2.7

13.9

360

N99

ICPC

Neurological disease other

5.5

13.9

N06AX12

ATC

bupropion; oral

1.9

13.8

206

1120

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.1

13.8

251

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

13.8

196

1050

ZXA10

NOMESCO Finland

Bilateral

1.6

13.8

370

2415

L01

ICPC

Neck symptom/complaint

1.6

13.6

353

2279

G91.0

ICD-10 Finland

Communicating hydrocephalus

+∞

13.5

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

+∞

13.5

R02

ICPC

Shortness of breath/dyspnoea

1.8

13.5

246

1433

L28

ICPC

Limited function/disability (L)

1.8

13.4

252

1482

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.3

13.4

126

564

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.9

13.4

279

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

5.3

13.4

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.1

13.4

148

713

R05

ICD-10 Finland

Cough

1.5

13.4

437

2987

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.1

13.4

157

776

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

4.9

13.4

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.6

13.4

329

2093

R39.1

ICD-10 Finland

Other difficulties with micturition

3.5

13.3

182

AA1AA

NOMESCO Finland

Head X-ray examination

8.6

13.2

PA7BD

NOMESCO Finland

CT angiography of neck and brain

4.9

13.2

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.8

13.2

225

1280

N06AX03

ATC

mianserin; oral

2.4

13.1

110

467

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

13.1

287

1767

C08CA05

ATC

nifedipine; systemic

2.3

13.1

121

538

F48.0

ICD-10 Finland

Neurasthenia

12.2

13.1

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

13.0

234

1355

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

13.0

356

2328

G04CA01

ATC

alfuzosin; oral

2.3

13.0

126

574

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

3.6

13.0

164

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

11.0

13.0

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

13.0

296

1846

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.5

13.0

103

425

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

16.8

13.0

A03

ICPC

Fever

1.5

13.0

479

3367

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

4.9

12.9

WX002

NOMESCO Finland

Sedation and analgesia

1.6

12.9

380

2532

G51.0

ICD-10 Finland

Bell palsy

3.0

12.9

258

H81.3

ICD-10 Finland

Other peripheral vertigo

3.1

12.8

231

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.0

12.8

155

780

N07CA01

ATC

betahistine; oral

2.1

12.8

141

680

M01AB55

ATC

diclofenac, combinations; oral

2.2

12.7

124

566

A03CA02

ATC

clidinium and psycholeptics; oral

2.4

12.7

108

462

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

12.7

901

7178

DFF00

NOMESCO Finland

Pure tone audiometry

2.0

12.7

169

880

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

12.7

157

797

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.7

12.7

147

S83.2

ICD-10 Finland

Tear of meniscus, current

2.0

12.7

169

881

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.3

12.7

189

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.0

12.6

243

M02AA07

ATC

piroxicam; topical

1.4

12.6

737

5677

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.2

12.6

128

597

G43

ICD-10 Finland

Migraine

1.9

12.6

184

994

ZXA05

NOMESCO Finland

Left side

1.5

12.6

465

3272

A03FA02

ATC

cisapride; oral, rectal

2.1

12.5

144

706

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

12.5

240

1419

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

12.5

230

1345

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

12.5

294

1851

C07AB02

ATC

metoprolol; systemic

1.6

12.4

303

1923

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

12.4

595

4413

B02AA02

ATC

tranexamic acid; systemic

1.5

12.4

429

2971

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.3

12.4

114

508

R03AC03

ATC

terbutaline; inhalant

1.6

12.4

364

2427

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.1

12.3

221

TKC22

NOMESCO Finland

Catheterisation instruction

4.4

12.3

R4120

NOMESCO Finland

Occupational therapy

2.1

12.3

142

700

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.1

12.2

117

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.1

12.2

146

730

SPAT1050

SPAT

Extensive neurological examination

3.2

12.2

195

C10AC01

ATC

colestyramine; oral

2.9

12.2

257

K59.0

ICD-10 Finland

Constipation

2.3

12.1

109

479

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.1

12.1

144

720

UDC00

NOMESCO Finland

Ear microscopy

2.0

12.1

158

819

K08.80

ICD-10 Finland

Toothache NOS

1.7

12.1

238

1423

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

12.1

195

1091

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.5

12.0

404

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.5

12.0

393

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

12.0

145

730

M22.4

ICD-10 Finland

Chondromalacia patellae

2.2

11.9

116

530

G72.9

ICD-10 Finland

Myopathy, unspecified

5.7

11.9

WZA90

NOMESCO Finland

Other doctors statement

1.4

11.9

579

4300

A06AC51

ATC

ispaghula, combinations; systemic

2.2

11.9

118

543

SPAT1255

SPAT

Intravenous administration of medicine

2.1

11.9

135

661

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

11.9

116

532

2AB04

NOMESCO Finland

11.7

11.8

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.8

11.8

274

N02CC02

ATC

naratriptan; oral

2.9

11.8

251

K02.1

ICD-10 Finland

Caries of dentine

1.3

11.8

1584

13879

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

11.7

102

443

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

11.7

251

1535

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

11.7

738

5746

R74

ICPC

Upper respiratory infection acute

1.4

11.7

881

7069

H02AB09

ATC

hydrocortisone; systemic

3.0

11.7

228

J35.0

ICD-10 Finland

Chronic tonsillitis

1.8

11.6

206

1187

-1

NOMESCO Finland

1.4

11.6

916

7400

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

11.6

262

1629

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.1

11.6

135

669

R01AD01

ATC

beclometasone; nasal

1.5

11.5

388

2667

R41.3

ICD-10 Finland

Other amnesia

3.8

11.5

124

ZX120

NOMESCO Finland

Intravenous

1.8

11.5

189

1067

JAH01

NOMESCO Finland

Laparoscopy

2.1

11.5

135

673

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

11.5

333

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.6

11.5

308

G95.9

ICD-10 Finland

Disease of spinal cord, unspecified

+∞

11.5

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

11.5

215

1264

A01AB09

ATC

miconazole; local oral

1.9

11.5

181

1007

J01MA14

ATC

moxifloxacin; systemic

1.8

11.4

188

1057

D02

ICPC

Abdominal pain epigastric

2.0

11.4

151

785

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.2

11.4

188

KMAK

NOMESCO Finland

1.3

11.4

1485

12921

WX290

NOMESCO Finland

Other blockade of nerve

1.3

11.4

1303

11125

H92.0

ICD-10 Finland

Otalgia

2.0

11.3

148

769

SPAT1097

SPAT

Recording of ECG

1.7

11.3

244

1499

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

11.2

154

814

R06AE09

ATC

levocetirizine; oral

1.5

11.2

411

2879

H93.1

ICD-10 Finland

Tinnitus

2.0

11.2

137

695

L12

ICPC

Hand/finger symptom/complaint

1.6

11.1

330

2200

N06AB03

ATC

fluoxetine; oral

1.6

11.1

303

1981

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.8

11.0

176

983

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

11.0

262

1649

R52.1

ICD-10 Finland

Chronic intractable pain

4.7

11.0

CS494

NOMESCO Finland

Other visual field testing

3.6

11.0

135

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

10.8

228

1387

SPAT1312

SPAT

General health counselling

1.4

10.8

795

6331

SPAT1104

SPAT

Monitoring of emergency patient

2.0

10.8

132

668

M75.8

ICD-10 Finland

Other shoulder lesions

2.3

10.8

436

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.6

10.8

132

J01MA12

ATC

levofloxacin; systemic

1.6

10.7

330

2219

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.7

10.7

230

1410

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

10.7

318

2123

N06AB05

ATC

paroxetine; oral

1.9

10.7

159

864

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

10.7

1049

8734

R96

ICPC

Asthma

1.8

10.7

192

1114

SPAT1283

SPAT

Restricted health certificate

1.4

10.6

627

4814

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

10.6

187

1080

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.2

10.5

109

515

K80

ICPC

Cardiac arrhythmia NOS

1.9

10.5

144

761

A02BC04

ATC

rabeprazole; oral

1.7

10.5

203

1208

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

10.5

133

682

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

10.5

1918

17414

SPAT1231

SPAT

Assessment of adjustments needed in living environment

5.0

10.5

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.4

10.4

370

S80.0

ICD-10 Finland

Contusion of knee

1.8

10.4

167

934

RD211

NOMESCO Finland

2.2

10.4

101

464

SFA00

NOMESCO Finland

Small filling

1.6

10.4

319

2143

J02AC02

ATC

itraconazole; systemic

1.5

10.4

421

3009

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

10.4

202

1203

M01AH03

ATC

valdecoxib; oral

2.0

10.4

135

702

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.2

10.3

100

457

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.4

10.3

374

3007

Kela drug reimbursment

Erenumab and fremanezumab

3.2

10.2

165

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

10.1

296

1968

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.4

10.1

139

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.9

10.1

155

854

R49.01

ICD-10 Finland

Functional dysphonia

2.4

10.1

333

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

10.1

1809

16322

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

2.4

10.1

345

Z2446

NOMESCO Finland

Social worker

1.9

10.1

158

875

XX3DW

NOMESCO Finland

Time consuming IT work

1.8

10.1

187

1098

R09

ICPC

Sinus symptom/complaint

1.6

10.1

246

1561

R03BB04

ATC

tiotropium bromide; inhalant

1.9

10.0

138

730

N07AA02

ATC

pyridostigmine; systemic

9.1

10.0

M77.4

ICD-10 Finland

Metatarsalgia

1.9

10.0

138

733

SPAT1210

SPAT

Application of cast or individual aid

2.2

10.0

101

474

S22.3

ICD-10 Finland

Fracture of rib

2.1

10.0

114

560

G93.0

ICD-10 Finland

Cerebral cysts

40.2

10.0

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

9.9

191

1133

U04

ICPC

Incontinence urine

2.4

9.9

324

R06.4

ICD-10 Finland

Hyperventilation

3.0

9.9

186

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.7

9.9

194

1158

R00.1

ICD-10 Finland

Bradycardia, unspecified

3.3

9.9

142

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.8

9.9

225

D11

ICPC

Diarrhoea

1.5

9.9

313

2121

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

26.1

9.8

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

9.8

150

825

R05FB02

ATC

cough suppressants and expectorants

1.3

9.8

774

6218

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

3.6

9.8

117

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

9.8

161

908

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

9.8

358

D06

ICPC

Abdominal pain localized other

1.7

9.8

205

1250

M35.7

ICD-10 Finland

Hypermobility syndrome

2.8

9.7

221

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.6

9.7

277

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.7

9.7

201

1220

N17

ICPC

Vertigo/dizziness

1.7

9.7

204

1243

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.8

9.7

166

951

N02AC04

ATC

dextropropoxyphene; oral

2.8

9.7

212

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

9.7

239

1521

B34.9

ICD-10 Finland

Viral infection, unspecified

2.3

9.7

393

H02AB07

ATC

prednisone; oral

1.5

9.6

292

1958

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

55.2

9.6

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

9.6

105

507

N06AX26

ATC

vortioxetine; oral

1.8

9.6

164

938

F06.7

ICD-10 Finland

Mild cognitive disorder

4.7

9.6

G04BD07

ATC

tolterodine; oral

2.5

9.6

298

L50.0

ICD-10 Finland

Allergic urticaria

2.4

9.6

317

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

9.6

109

536

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

9.6

120

614

N02AJ13

ATC

tramadol and paracetamol; systemic

3.0

9.5

174

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

3.3

9.5

141

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

9.5

199

1211

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

6.0

9.5

P01

ICPC

Feeling anxious/nervous/tense

1.5

9.4

335

2325

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.3

9.4

384

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

9.4

549

4201

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.6

9.3

253

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

21.8

9.3

6421

FHL

Appendicectomy

1.9

9.3

137

746

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

9.3

467

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.4

9.3

309

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.8

9.3

157

894

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

9.3

1053

8897

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

9.3

1508

13351

WZC30

NOMESCO Finland

Teaching

1.6

9.2

253

1652

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

6.4

9.2

N06AA12

ATC

doxepin; systemic

2.1

9.2

460

R01AD05

ATC

budesonide; nasal

1.7

9.2

198

1216

EMB10

NOMESCO Finland

Tonsillectomy

1.7

9.2

209

1301

G93.3

ICD-10 Finland

Postviral fatigue syndrome

7.3

9.2

G47.4

ICD-10 Finland

Narcolepsy and cataplexy

13.7

9.2

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.3

9.2

355

N02CX04

ATC

2.9

9.1

184

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

2.8

9.1

197

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

3.6

9.1

109

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.5

9.1

289

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.3

9.1

339

PA2CG

NOMESCO Finland

Extensive MRI examination of vessels in the head with high intensity magnet

8.3

9.1

A06AX04

ATC

linaclotide; oral

8.3

9.1

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.6

9.0

239

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.4

9.0

320

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

9.0

398

2893

M24.2

ICD-10 Finland

Disorder of ligament

2.9

9.0

180

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

9.0

116

603

R12

ICD-10 Finland

Heartburn

1.8

9.0

163

951

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

9.0

200

1239

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.8

8.9

194

R20.1

ICD-10 Finland

Hypoaesthesia of skin

5.2

8.9

R41.0

ICD-10 Finland

Disorientation, unspecified

3.3

8.9

127

M48.0

ICD-10 Finland

Spinal stenosis

1.8

8.9

150

855

K07.61

ICD-10 Finland

Cracking jaw joint

2.6

8.8

254

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.2

8.8

424

N03AX14

ATC

levetiracetam; systemic

2.7

8.8

219

R05

ICPC

Cough

1.4

8.8

515

3931

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.1

8.8

486

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

8.8

533

4097

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

8.8

124

664

L86

ICPC

Back syndrome with radiating pain

1.9

8.8

122

650

N06AX22

ATC

agomelatine; oral

2.4

8.7

282

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

8.7

154

891

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

8.7

397

J01DA06

ATC

[U] cefuroxime; systemic

1.5

8.7

343

2433

A69.2

ICD-10 Finland

Lyme disease

2.0

8.7

105

530

RJ630

NOMESCO Finland

14.1

8.7

O89.4

ICD-10 Finland

Spinal and epidural anaesthesia-induced headache during the puerperium

14.1

8.7

R06AX13

ATC

loratadine; oral

1.4

8.7

434

3225

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

8.6

412

N20.1

ICD-10 Finland

Calculus of ureter

2.4

8.6

297

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.9

8.6

123

664

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

8.6

106

539

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.8

8.6

197

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.0

8.5

168

4AA23

NOMESCO Finland

16.3

8.5

G01AF05

ATC

econazole; vaginal

1.6

8.5

226

1467

K04

ICPC

Palpitations/awareness of heart

1.9

8.5

114

598

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.8

8.5

182

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.6

8.5

100

E0000UV

ATC

1.3

8.5

959

8070

N76.0

ICD-10 Finland

Acute vaginitis

1.6

8.5

207

1315

N05CD07

ATC

temazepam; oral

1.7

8.5

169

1012

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

4.9

8.5

7804A

ICD-9 Finland

General symptoms, Dizziness and giddiness

6.4

8.5

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

8.5

231

1509

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.2

8.4

400

A07AA02

ATC

nystatin; oral

2.0

8.4

107

552

SPAT1053

SPAT

Memory test

1.9

8.4

127

699

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.6

8.4

193

1209

TKD00

NOMESCO Finland

Dilatation of urethra

4.8

8.4

N02CD01

ATC

erenumab; parenteral

3.3

8.3

123

K05

ICPC

Irregular heartbeat other

2.8

8.3

195

G95.0

ICD-10 Finland

Syringomyelia and syringobulbia

+∞

8.3

9970A

ICD-9 Finland

Complications affecting specified body systems, not elsewhere classified, Central nervous system complications

+∞

8.3

AAF15

NOMESCO Finland

Ventriculoatrial shunt

+∞

8.3

G57.6

ICD-10 Finland

Lesion of plantar nerve

2.9

8.3

166

SPAT1081

SPAT

Cardiorespiratory global assessment

2.2

8.3

374

A02BA04

ATC

nizatidine; systemic

1.9

8.3

126

693

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

8.5

8.3

R01AD11

ATC

triamcinolone; nasal

1.6

8.3

220

1427

U01

ICPC

Dysuria/painful urination

1.7

8.3

177

1083

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

8.3

164

985

R27.0

ICD-10 Finland

Ataxia, unspecified

9.5

8.3

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

8.2

114

608

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

4.4

8.2

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.8

8.2

190

PHD99

NOMESCO Finland

Resection of other vein

1.8

8.2

133

748

A28

ICPC

Limited function/disability NOS

1.7

8.2

160

956

F05

ICPC

Visual disturbance other

2.6

8.2

214

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

8.2

120

654

PA2DG

NOMESCO Finland

Very extensive MRI examination of vessels in the head with high intensity magnet

14.5

8.2

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

3.4

8.2

109

A05

ICPC

Feeling ill

1.7

8.2

163

982

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

8.1

154

911

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.4

8.1

279

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.6

8.1

224

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

8.1

481

B01AA03

ATC

warfarin; systemic

1.6

8.1

193

1220

A11

ICPC

Chest pain NOS

1.9

8.1

119

651

132

Kela drug reimbursment

Sarcoidosis

6.8

8.1

G01AA10

ATC

clindamycin; vaginal

1.4

8.0

438

3301

WX400

NOMESCO Finland

Inhalation anesthesy

1.8

8.0

124

687

UJD02

NOMESCO Finland

Gastroscopy

2.0

8.0

472

N02AA03

ATC

hydromorphone; systemic, rectal

8.9

8.0

M01AX01

ATC

nabumetone; oral

2.2

8.0

367

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.8

8.0

172

R4110

NOMESCO Finland

Physiotherapy

1.4

8.0

519

4027

G43.2

ICD-10 Finland

Status migrainosus

5.5

8.0

G04BD04

ATC

oxybutynin; oral, transdermal

2.1

8.0

404

UDM02

NOMESCO Finland

Sinoscopy

2.5

7.9

231

L13

ICPC

Hip symptom/complaint

1.5

7.9

255

1733

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

7.9

150

886

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.8

7.9

134

764

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

3.0

7.9

145

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.4

7.9

259

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

7.9

225

1488

O99.80

ICD-10 Finland

The fear of childbirth

1.7

7.9

175

1086

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

2.5

7.9

223

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.0

7.8

101

526

M54

ICD-10 Finland

Dorsalgia

1.5

7.8

267

1839

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.7

7.8

185

ZY010

NOMESCO Finland

Hospital outpatient

1.8

7.8

139

808

L11

ICPC

Wrist symptom/complaint

1.6

7.8

192

1222

M54.8

ICD-10 Finland

Other dorsalgia

2.0

7.8

502

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

5.7

7.8

R06.5

ICD-10 Finland

Mouth breathing

1.6

7.8

176

1096

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

7.8

122

679

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

8.5

7.8

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.1

7.8

130

M01AC02

ATC

tenoxicam; systemic, rectal

2.2

7.7

359

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.7

7.7

194

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.5

7.7

237

PHD76

NOMESCO Finland

Resection of long saphenous vein

2.0

7.7

494

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

7.7

152

912

SPAT1307

SPAT

Psychosocial counselling and guidance

1.6

7.7

197

1268

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.9

7.7

159

A86

ICD-10 Finland

Unspecified viral encephalitis

7.4

7.7

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

7.4

7.7

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

7.7

134

776

M09AX01

ATC

hyaluronic acid; parenteral

2.4

7.7

269

H15.1

ICD-10 Finland

Episcleritis

2.9

7.7

152

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.8

7.7

137

796

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

7.6

158

961

R07.0

ICD-10 Finland

Pain in throat

1.7

7.6

166

1022

M77.1

ICD-10 Finland

Lateral epicondylitis

1.6

7.6

195

1256

SPAT1098

SPAT

Exercise ECG

3.3

7.6

110

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.6

7.6

214

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

7.6

198

1281

L04AA40

ATC

cladribine; oral

18.4

7.6

U02

ICPC

Urinary frequency/urgency

1.5

7.6

268

1858

J46

ICD-10 Finland

Status asthmaticus

2.3

7.6

291

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

7.6

140

823

PA7DG

NOMESCO Finland

Very extended MRI examination of vessesl in brain and neck with high intensity magnet

25.1

7.6

N06AX05

ATC

trazodone; oral

2.3

7.6

303

P06

ICPC

Sleep disturbance

1.5

7.6

232

1562

M01AB08

ATC

etodolac; oral

1.7

7.6

152

917

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

5.1

7.5

H81.4

ICD-10 Finland

Vertigo of central origin

6.2

7.5

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

7.5

177

R03AC12

ATC

salmeterol; inhalant

2.1

7.5

372

K04.0

ICD-10 Finland

Pulpitis

1.5

7.5

274

1916

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

7.5

106

572

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.7

7.5

186

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

7.5

595

4762

J01DC02

ATC

cefuroxime; systemic

1.7

7.5

144

857

SXC05

NOMESCO Finland

Other oral or dental procedure

1.7

7.5

141

837

S50.0

ICD-10 Finland

Contusion of elbow

2.3

7.4

298

N18

ICPC

Paralysis/weakness

3.6

7.4

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

7.4

117

653

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

4.4

7.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

7.4

194

1253

B01AC04

ATC

clopidogrel; oral

1.8

7.4

128

736

JEA00

NOMESCO Finland

Appendectomy

1.7

7.4

159

976

9889

FHL

Other similar procedure in operating room or anesthesia

80.3

7.4

Z30.2

ICD-10 Finland

Sterilization

1.4

7.4

306

2192

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

7.4

103

552

G03.9

ICD-10 Finland

Meningitis, unspecified

7.7

7.4

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.8

7.4

115

642

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.8

7.4

120

677

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

7.4

207

1362

G62.8

ICD-10 Finland

Other specified polyneuropathies

5.6

7.4

L05

ICPC

Flank/axilla symptom/complaint

1.9

7.4

107

583

N81.6

ICD-10 Finland

Rectocele

1.8

7.3

120

679

KCV04

NOMESCO Finland

Distension of bladder with fluid

3.7

7.3

M01AX05

ATC

glucosamine; oral

1.5

7.3

245

1680

L17

ICPC

Foot/toe symptom/complaint

1.3

7.3

492

3838

Z98.2

ICD-10 Finland

Presence of cerebrospinal fluid drainage device

+∞

7.3

G04BD11

ATC

fesoterodine; oral

2.7

7.3

183

M02AA10

ATC

ketoprofen; topical

1.4

7.3

303

2176

R03AC13

ATC

formoterol; inhalant

1.9

7.3

504

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

2.0

7.3

477

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

7.3

578

4620

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.1

7.2

378

R68.2

ICD-10 Finland

Dry mouth, unspecified

5.8

7.2

L02

ICPC

Back symptom/complaint

1.5

7.2

219

1472

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

7.2

147

892

H81.0

ICD-10 Finland

Ménière disease

2.8

7.2

161

R06AX22

ATC

ebastine; oral

1.4

7.2

452

3488

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.2

7.2

344

N32.83

ICD-10 Finland

Nozzle synergy in the bladder neck

7.3

7.2

R07.2

ICD-10 Finland

Precordial pain

3.0

7.2

127

N06

ICPC

Sensation disturbance other

3.5

7.2

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.8

7.2

109

602

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

2.1

7.1

382

O74.5

ICD-10 Finland

Spinal and epidural anaesthesia-induced headache during labour and delivery

20.1

7.1

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.8

7.1

150

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

7.1

940

8025

K04.08

ICD-10 Finland

Other specified pulpit

1.6

7.1

186

1205

SPAT1357

SPAT

Monitoring of problem during pregnancy

1.9

7.1

533

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

3.6

7.1

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

7.1

328

NA1CM

NOMESCO Finland

Cervical spine extensive MRI examination with 3 Tesla magnet

8.8

7.0

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

7.0

467

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.8

7.0

106

585

R52.0

ICD-10 Finland

Acute pain

2.0

7.0

403

G56.4

ICD-10 Finland

Causalgia

4.7

7.0

S92.5

ICD-10 Finland

Fracture of other toe

2.1

7.0

343

R83

ICPC

Respiratory infection other

1.3

7.0

734

6091

Z50.1

ICD-10 Finland

Other physical therapy

1.9

7.0

102

557

N80.0

ICD-10 Finland

Endometriosis of uterus

2.1

7.0

331

H53.4

ICD-10 Finland

Visual field defects

2.9

7.0

130

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

6.9

154

954

GD1AA

SPAT

1.6

6.9

192

1263

L15

ICPC

Knee symptom/complaint

1.4

6.9

390

2954

N06BA04

ATC

methylphenidate; oral

2.1

6.9

359

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

6.9

279

1991

G04BD09

ATC

trospium; oral

2.8

6.9

154

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

6.9

107

598

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

6.8

645

5273

SGA01

NOMESCO Finland

Tooth opening as first aid

1.4

6.8

419

3219

N07BC02

ATC

methadone; systemic

8.3

6.8

J20

ICD-10 Finland

Acute bronchitis

1.5

6.8

201

1342

SPAT1324

SPAT

Screening procedure

1.3

6.8

588

4751

S90.0

ICD-10 Finland

Contusion of ankle

2.5

6.8

208

O21.9

ICD-10 Finland

Vomiting of pregnancy, unspecified

2.4

6.8

227

P01BA02

ATC

hydroxychloroquine; oral

1.6

6.8

170

1090

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

6.8

237

1644

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

6.1

6.8

O47.1

ICD-10 Finland

False labour at or after 37 completed weeks of gestation

1.7

6.8

122

713

79199

ICD-8 Finland

Headache

3.8

6.8

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

40.1

6.8

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.9

6.7

535

UJF92

NOMESCO Finland

Capsular endoscopy

2.5

6.7

210

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.8

6.7

144

SPAT1059

SPAT

Spirometry at the office

1.9

6.7

492

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

6.7

469

3673

RF420

NOMESCO Finland

3.0

6.7

122

G03DC03

ATC

lynestrenol; oral

2.1

6.7

349

63497

ICD-8 Finland

Other complications of pregnancy, Partus prematurus imminens, alibi non classificabilis

2.7

6.7

160

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

6.7

207

1398

XPX04

NOMESCO Finland

Angioscopy

4.4

6.6

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.6

6.6

176

L99

ICPC

Musculoskeletal disease other

2.7

6.6

162

SPAT1058

SPAT

PEF monitoring instruction

1.6

6.6

151

944

3AX01

NOMESCO Finland

5.2

6.6

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.5

6.6

196

1311

R25.1

ICD-10 Finland

Tremor, unspecified

2.4

6.6

224

L20

ICPC

Joint symptom/complaint NOS

2.0

6.6

417

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.8

6.6

101

563

XF402

NOMESCO Finland

ECG with work load test

1.6

6.6

146

908

RS221

NOMESCO Finland

2.9

6.6

133

214

Kela drug reimbursment

Severe and chronic narcolepsy

12.3

6.6

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

6.6

527

4211

XJH00

NOMESCO Finland

Transanal ultrasonography

2.2

6.6

266

ZXD35

NOMESCO Finland

Usual procedure

2.2

6.5

299

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

6.5

495

3925

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.3

6.5

258

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

2.6

6.5

172

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

6.5

463

3636

WX702

NOMESCO Finland

Supraglottic ventilation device

1.7

6.5

116

676

A02BX02

ATC

sucralfate; oral

2.1

6.5

314

R4150

NOMESCO Finland

Neuropsychological rehabilitation

3.8

6.5

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.6

6.5

159

1016

SPAT1325

SPAT

Vaccination

1.3

6.4

626

5135

L04AX01

ATC

azathioprine; systemic

1.8

6.4

105

597

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

6.4

110

633

NHG70

NOMESCO Finland

Arthroplasty of first tarsometatarsal joint

3.2

6.4

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

2.1

6.4

317

F32.1

ICD-10 Finland

Moderate depressive episode

1.6

6.4

157

1003

N05AB04

ATC

prochlorperazine; systemic, rectal

2.5

6.4

193

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

6.4

466

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.5

6.3

179

O20.0

ICD-10 Finland

Threatened abortion

1.9

6.3

467

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

6.3

173

1134

J04.0

ICD-10 Finland

Acute laryngitis

1.8

6.3

512

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

6.3

106

609

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.0

6.3

116

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

5.2

6.3

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

6.3

138

853

R06AX26

ATC

fexofenadine; oral

1.6

6.3

173

1137

D07AC01

ATC

betamethasone; topical

1.3

6.3

724

6062

L03AB13

ATC

peginterferon beta-1a; parenteral

11.0

6.3

G36.0

ICD-10 Finland

Neuromyelitis optica [Devic]

11.0

6.3

RF410

NOMESCO Finland

3.2

6.3

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.6

6.3

174

1143

L09

ICPC

Arm symptom/complaint

1.8

6.3

518

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

3.6

6.3

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

3.6

6.3

E000002

ATC

1.4

6.3

272

1967

R19.5

ICD-10 Finland

Other faecal abnormalities

3.3

6.3

G91.8

ICD-10 Finland

Other hydrocephalus

+∞

6.3

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

+∞

6.3

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

+∞

6.3

G90.2

ICD-10 Finland

Horner syndrome

+∞

6.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

6.2

112

655

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.1

6.2

306

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

6.2

278

2025

C05AA08

ATC

fluocortolone; rectal, topical

1.4

6.2

271

1962

R5599

NOMESCO Finland

Other rehabilitation service

2.2

6.2

273

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

6.2

122

734

M01AG01

ATC

mefenamic acid; oral

2.0

6.2

343

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.9

6.2

118

WX892

NOMESCO Finland

Monitored bed care

1.7

6.2

117

698

N20.9

ICD-10 Finland

Urinary calculus, unspecified

2.4

6.1

213

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

6.1

177

1174

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.6

6.1

138

862

NGA20

NOMESCO Finland

Exploration of soft tissue knee or lower leg, open

7.7

6.1

B01AC07

ATC

dipyridamole; systemic

3.4

6.1

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

6.1

128

784

M05BA07

ATC

risedronic acid; oral

2.6

6.1

160

R46.8

ICD-10 Finland

Other symptoms and signs involving appearance and behaviour

12.5

6.1

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

6.1

555

S20.2

ICD-10 Finland

Contusion of thorax

1.8

6.1

490

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

3.9

6.1

R25.2

ICD-10 Finland

Cramp and spasm

2.4

6.1

205

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

6.1

379

Z00.8

ICD-10 Finland

Other general examinations

1.6

6.0

150

962

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

4.4

6.0

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.1

6.0

330

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

3.2

6.0

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

6.0

171

1131

M03AX01

ATC

botulinum toxin; parenteral

2.6

6.0

155

LCD10

NOMESCO Finland

Vaginal hysterectomy

2.0

6.0

382

N39.3

ICD-10 Finland

Stress incontinence

1.6

6.0

137

860

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

5.2

6.0

JEA01

NOMESCO Finland

Laparoscopic appendectomy

1.7

6.0

105

612

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

297

232

14.05

313.00

1.2

1.1

mg/l

31.7

34.8

0.46

246

188

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

294

226

14.27

312.76

1.1

1.0

mg/l

213.5

220.6

0.18

255

191

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

572

553

12.46

307.65

1.3

1.2

mg/l

383.6

486.1

4.35

542

524

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

506

483

12.32

307.65

1.4

1.3

e6/l

1986.7

9681.7

0.48

429

383

(3044290) Cell count panel - Cerebral spinal fluid

439

462

10.90

307.65

1.3

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

500

489

12.00

307.65

1.3

1.1

mmol/l

3.5

3.7

2.83

466

459

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

508

483

12.38

307.65

1.3

1.2

e6/l

15.2

24.8

0.55

413

364

(4027681)

254

181

15.20

281.73

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

274

225

13.26

279.77

1.1

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

274

253

11.78

259.35

1.1

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

207

159

13.88

219.36

1.1

1.0

u/l

1.0

1.1

0.20

(3005719) IgG [Mass/volume] in Serum or Plasma

578

1833

3.65

152.08

2.4

2.5

g/l

10.1

10.6

2.81

522

1689

(3023410) Appearance of Cerebral spinal fluid

193

233

8.77

149.20

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

142

111

13.36

148.44

1.3

1.1

62.0

68.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

570

1866

3.52

142.21

2.7

2.3

au/ml

33.4

22.3

0.94

150

(3016018) Differential panel - Cerebral spinal fluid

188

235

8.45

141.22

1.3

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

538

1728

3.56

137.99

1.4

1.3

au/ml

54.5

41.9

0.37

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

155

168

9.66

130.08

1.3

1.2

mmol/l

1.7

2.0

1.55

144

157

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1136

5675

2.58

129.99

2.4

2.0

u/l

120.7

220.9

3.27

1089

5384

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

138

157

9.15

111.51

1.3

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1234

7207

2.18

91.29

3.4

2.7

ng/l

24.4

44.3

1.21

570

3554

(3013826) Glucose [Moles/volume] in Serum or Plasma

1874

12858

2.16

91.03

4.6

4.2

mmol/l

6.1

6.4

12.22

1773

11716

(3024561) Albumin [Mass/volume] in Serum or Plasma

1426

8818

2.14

90.96

4.3

4.5

g/l

37.2

36.7

3.05

1348

8249

(3006315) Basophils [#/volume] in Blood

1818

12542

2.09

84.26

7.1

5.8

e9/l

0.0

0.07

1679

11022

(3001604) Monocytes [#/volume] in Blood

1811

12517

2.07

82.99

7.0

5.8

e9/l

0.5

3.67

1674

11015

(3019198) Lymphocytes [#/volume] in Blood

1855

12980

2.07

81.61

7.1

5.8

e9/l

1.9

2.0

3.13

1734

11684

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1536

10052

2.05

81.19

5.8

5.9

mmol/l

1.2

0.16

1303

8514

(3013115) Eosinophils [#/volume] in Blood

1854

13002

2.06

80.66

7.2

6.0

e9/l

0.2

0.26

1723

11648

(3013707) Erythrocyte sedimentation rate by Westergren method

2375

18389

2.25

78.07

4.9

3.7

mm/h

8.5

9.8

8.15

2273

17238

(3018677) aPTT in Platelet poor plasma by Coagulation assay

601

2754

2.47

77.22

1.9

2.2

28.7

29.5

3.72

577

2659

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1170

7057

2.06

76.18

2.8

2.4

u/l

54.0

56.3

1.57

1086

6564

(3032080) INR in Blood by Coagulation assay

1194

7277

2.04

75.35

6.7

6.1

inr

1.1

0.40

398

2344

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

12.77

71.88

1.1

1.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2304

17914

2.11

70.53

7.4

6.8

u/l

70.3

74.3

8.37

2195

16956

(3036481) Cortisol [Moles/volume] in Serum or Plasma

525

2366

2.47

69.35

2.3

2.0

nmol/l

366.0

374.4

0.48

494

2188

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1366

8957

1.94

67.91

5.1

5.3

mmol/l

1.2

0.37

1274

8194

(3037522) Nuclear Ab [Titer] in Serum

740

3902

2.18

67.39

1.5

1.4

titre

499.0

547.2

0.29

139

786

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1634

11480

1.90

64.74

5.1

5.6

umol/l

9.3

10.3

6.02

1550

10860

(3013650) Neutrophils [#/volume] in Blood by Automated count

1929

14327

1.92

64.07

8.9

8.7

e9/l

3.9

4.0

1.20

1787

12637

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

866

4972

2.03

62.18

1.4

1.3

iu/ml

21.1

25.2

0.54

258

1533

(3035350) Ketones [Presence] in Urine by Test strip

1701

12318

1.84

59.08

4.5

3.1

estimate

0.0

0.88

385

2337

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

287

1031

2.97

58.92

2.2

2.0

u/l

39.4

39.9

0.19

272

951

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

10.52

58.89

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

1717

12483

1.84

58.74

4.5

3.1

estimate

0.0

1.32

391

2334

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

9.90

58.16

1.2

1.1

19.8

23.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

301

1120

2.87

57.94

1.4

1.3

u/ml

1.6

0.9

0.30

(3031040) Bacteria [#/volume] in Urine by Automated count

2092

16215

1.89

57.87

5.7

3.7

e6/l

302.5

1239.9

1.48

165

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

946

5737

1.93

57.15

1.9

1.7

mg/l

0.8

0.9

0.65

686

4229

(3021601) Nitrite [Presence] in Urine by Test strip

1697

12389

1.82

56.29

5.9

4.3

estimate

0.0

0.50

398

2401

(3037467) Urinalysis macro (dipstick) panel - Urine

2182

17218

1.90

56.16

5.3

3.8

—

(3019069) Monocytes/100 leukocytes in Blood

1638

11868

1.81

55.36

7.4

6.1

8.2

8.1

0.38

1585

11207

(3006504) Eosinophils/100 leukocytes in Blood

1627

11787

1.80

54.79

7.2

5.8

2.8

0.31

1567

11033

(3015736) pH of Urine

1367

9434

1.80

53.95

4.0

2.9

—

5.8

—

(3022096) Basophils/100 leukocytes in Blood

1578

11370

1.79

53.74

7.3

5.9

0.7

0.76

1512

10664

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

8.58

53.73

1.1

ng/l

31.3

344.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

111

7.28

53.42

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

10.18

53.17

1.2

1.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

1673

12359

1.77

51.39

7.2

5.8

29.6

0.10

1611

11622

(3019550) Sodium [Moles/volume] in Serum or Plasma

2864

25264

2.76

51.36

14.8

10.6

mmol/l

139.8

139.6

3.81

2828

24587

(3018010) Neutrophils/100 leukocytes in Blood

1654

12196

1.76

50.97

7.0

5.7

56.2

56.4

0.27

1600

11498

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1443

10244

1.76

50.68

2.5

2.2

nmol/l

77.8

74.3

5.23

1359

9521

(3029937) Albumin [Presence] in Urine by Test strip

1010

6453

1.84

50.67

5.0

3.4

estimate

0.0

0.28

394

2356

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1382

9711

1.76

50.13

4.6

3.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

794

4721

1.92

49.78

1.4

1.3

u/ml

4.6

9.7

3.47

355

1998

(42870588) Differential panel, method unspecified - Blood

1187

7994

1.79

49.76

7.0

5.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2866

25360

2.72

49.75

14.9

10.7

mmol/l

3.9

3.34

2822

24621

(3020630) Protein [Mass/volume] in Serum or Plasma

301

1251

2.56

46.33

2.0

2.4

g/l

67.9

67.7

0.24

282

1163

(40760892) CBC W Ordered Manual Differential panel - Blood

974

6306

1.79

45.83

4.8

4.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

7.99

45.60

1.0

ng/l

736.2

754.0

0.08

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

7.89

45.12

1.0

ng/l

329.0

301.5

0.22

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

7.79

44.65

1.0

ng/l

54.3

40.7

0.81

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

9.01

44.61

2.5

2.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2484

21068

1.90

43.53

5.1

4.1

pmol/l

14.5

14.4

2.47

2364

19695

(3015377) Calcium [Moles/volume] in Serum or Plasma

1056

7082

1.74

43.51

2.5

3.1

mmol/l

2.3

2.33

944

6408

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

718

4321

1.86

42.41

1.7

1.6

pmol/l

32855292.6

37567410.1

0.08

627

3732

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

6.60

42.15

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

7.39

41.98

1.1

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

150

5.52

41.78

1.1

nmol/l

0.1

6.2

1.01

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2889

26024

2.62

41.64

15.7

10.5

mg/l

16.4

20.0

9.72

2353

19992

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

7.17

41.54

1.2

1.6

—

(3018418) pH of Serum or Plasma

909

5918

1.76

41.11

3.3

3.6

7.4

1.17

193

1133

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

158

501

3.27

39.95

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

822

5236

1.78

39.90

4.7

3.3

kg/l

1.0

0.28

113

783

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1153

8146

1.66

37.86

2.0

1.8

pmol/l

99.6

98.5

0.35

673

4374

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2727

24223

2.05

36.76

5.9

4.7

mu/l

1.7

2.0

2.28

2609

22878

(3000850) Epithelial cells [#/volume] in Urine

707

4399

1.79

36.74

3.2

2.3

e6/l

5.7

7.7

3.79

636

3849

(3023368) Bacteria identified in Blood by Culture

752

4803

1.75

35.53

4.0

3.9

—

(3048689) Calprotectin [Mass/mass] in Stool

625

3785

1.82

35.41

2.3

2.5

ug/g

104.2

102.5

0.04

486

3013

(3002582) Erythrocytes [#/volume] in Urine

939

6400

1.67

34.78

3.8

2.8

e6/l

131.0

100.8

0.10

758

4798

(3030467) Casts [#/volume] in Urine by Automated count

872

5834

1.69

34.64

3.6

2.7

e6/l

0.1

0.3

5.66

702

4301

(3028026) IgM [Mass/volume] in Serum or Plasma

303

1437

2.23

34.33

2.1

1.8

g/l

1.2

1.4

1.67

288

1331

(40761535) Cells panel - Urine sediment

322

1569

2.17

34.11

4.1

3.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

982

6802

1.65

34.00

1.4

1.3

u/ml

1.5

1.4

0.04

295

1921

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

8.14

33.74

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

586

3530

1.81

33.61

3.3

2.9

ng/l

111.2

496.3

3.92

301

2124

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

8.00

33.25

1.1

—

(3011412) CD3 cells [#/volume] in Blood

251

3.91

32.47

2.5

2.4

e9/l

1.1

1.3

0.89

151

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

8.06

31.99

1.1

—

(3044889) 12 lead EKG panel

1938

15930

1.58

31.46

3.5

2.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

631

3972

1.74

30.84

2.4

2.7

ng/l

406.6

782.8

6.04

519

3219

(3021589) Normoblasts [#/volume] in Blood

1444

11157

1.55

30.53

10.5

8.2

e9/l

0.0

0.98

1260

9112

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

418

2332

1.92

30.32

6.4

5.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

525

3155

1.80

30.04

1.8

1.7

nmol/l

1209.7

1168.5

0.53

422

2460

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

494

2917

1.82

29.95

1.9

1.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

7.59

29.72

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1010

7239

1.59

29.47

3.8

2.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

402

2235

1.92

29.42

2.7

2.2

u/l

8042.0

5090.4

0.88

139

909

(36304419) Bacteria [Presence] in Urine

851

5868

1.62

29.13

3.6

2.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

199

4.10

28.98

2.1

2.0

14.3

12.5

0.55

(3026008) Bacteria identified in Urine by Culture

911

6397

1.60

28.88

3.4

2.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

664

4315

1.69

28.63

1.6

1.4

nmol/l

20.2

20.9

0.70

592

3828

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

7.41

28.42

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

514

3118

1.78

28.36

3.0

3.4

mmol/l

0.8

1.97

479

2937

(3018095) Leukocytes [#/volume] in Urine

1083

7946

1.56

28.25

4.6

3.3

e6/l

29.9

79.1

3.56

826

5274

(1175426) CD3 cells/100 lymphocytes in Blood

204

4.00

28.03

2.1

2.0

76.3

74.2

0.70

198

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

10.09

27.39

1.1

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

10.09

27.39

1.1

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

135

490

2.84

26.98

1.3

1.2

—

(3026782) Osmolality of Urine

628

4082

1.68

26.85

3.3

2.5

mosm/kgh2o

544.4

542.4

0.08

562

3478

(3011397) Hemoglobin [Presence] in Urine by Test strip

785

5476

1.58

24.95

4.6

3.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

186

3.94

24.81

2.0

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

822

5809

1.56

24.64

1.6

1.4

g/l

2.1

2.2

1.20

580

3740

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1616

13157

1.48

24.42

3.3

2.9

ug/l

78.2

84.6

1.04

1548

12449

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

192

866

2.30

24.40

2.0

g/l

1.2

0.37

182

814

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

342

1918

1.88

24.16

1.8

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

207

971

2.21

23.94

6.0

7.5

mmol/l

24.4

24.3

0.25

194

902

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

160

4.13

23.92

1.1

miu/ml

2070.8

1477.6

2.72

160

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

345

1956

1.86

23.53

1.8

1.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

177

3.91

23.20

2.7

2.6

e9/l

0.2

0.20

152

(40768797) Stomach Pathology biopsy report

509

3242

1.68

23.19

1.3

1.2

—

(3013512) EKG study

768

5422

1.55

22.85

3.4

2.9

—

(3019060) Gas panel - Arterial blood

207

990

2.17

22.81

4.3

5.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

184

839

2.27

22.79

2.0

g/l

0.2

0.19

174

790

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

792

5634

1.54

22.76

2.3

2.1

mg/l

2.7

2.8

0.41

708

4862

(3020891) Body temperature

146

601

2.50

22.75

5.0

4.6

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

10.49

22.68

1.2

1.0

48.6

77.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1460

11761

1.46

22.64

4.4

3.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

183

3.78

22.15

2.8

2.6

e6/l

494.1

580.0

0.65

153

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1110

8513

1.47

22.04

3.5

3.1

u/l

27.6

30.8

2.15

1051

8133

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2931

27553

2.17

21.70

11.4

8.7

u/l

25.4

26.0

1.34

2873

26794

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

186

871

2.21

21.60

1.7

1.6

iu/ml

0.0

0.4

1.21

164

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2635

24002

1.65

21.53

4.0

3.6

mmol/l

5.6

5.7

3.02

2505

22469

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

7.90

21.28

1.2

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

524

3441

1.63

21.02

2.9

2.4

e6/l

1.0

1.2

0.43

312

1857

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

958

7192

1.48

20.96

1.8

1.6

—

(3016502) Oxygen saturation in Arterial blood

288

1601

1.88

20.82

5.7

8.6

96.6

96.0

1.07

277

1548

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

518

3412

1.62

20.48

2.5

2.6

mmol/l

2.4

1.23

452

2990

(3004588) Protein electrophoresis panel - Serum or Plasma

200

993

2.08

19.99

2.2

2.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

221

3.36

19.96

2.1

2.3

43.8

46.6

0.22

(40761511) CBC panel - Blood by Automated count

2936

27717

2.12

19.86

14.5

9.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

182

879

2.14

19.55

2.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2433

21917

1.51

19.14

4.6

4.4

mmol/mol

37.4

38.1

3.87

2304

20714

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

310

1827

1.77

18.47

5.7

8.0

kpa

4.9

5.1

2.18

297

1746

(3027801) Oxygen [Partial pressure] in Arterial blood

310

1827

1.77

18.47

5.7

8.0

kpa

12.8

13.2

0.58

299

1751

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.48

18.23

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

273

1555

1.83

18.22

5.0

3.7

kpa

5.8

0.29

268

1503

(3007853) Bacteria identified in Skin by Aerobe culture

427

2760

1.63

18.06

1.8

1.6

—

(3025159) Blasts/100 leukocytes in Blood

299

1759

1.77

17.91

4.6

4.4

0.1

0.5

0.80

381

(3014576) Chloride [Moles/volume] in Serum or Plasma

342

2098

1.71

17.66

6.9

7.0

mmol/l

105.4

104.6

2.62

336

2055

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2123

18759

1.42

17.35

3.5

2.9

u/l

36.9

38.5

0.57

2026

17902

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

225

1228

1.90

17.17

2.3

2.0

ug/l

3.6

6.8

3.75

195

1098

(3003396) Base excess in Arterial blood by calculation

305

1827

1.74

17.14

5.7

8.0

mmol/l

1.3

0.9

1.16

244

1406

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

140

642

2.24

17.13

1.4

1.2

u/ml

21.1

35.5

0.92

(3002173) Hemoglobin [Mass/volume] in Arterial blood

264

1521

1.80

16.95

6.0

8.9

g/l

125.4

123.1

1.12

253

1466

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

141

653

2.21

16.85

4.4

6.0

1.6

1.7

0.16

132

611

(3002179) Metamyelocytes/100 leukocytes in Blood

298

1782

1.74

16.85

4.3

4.1

0.8

0.6

0.32

366

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

171

856

2.06

16.73

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

165

816

2.08

16.68

1.4

1.3

u/ml

17.1

40.9

1.09

(3017181) Myelocytes/100 leukocytes in Blood

316

1927

1.71

16.65

4.6

4.3

1.2

0.9

0.42

488

(3007930) Methemoglobin/Hemoglobin.total in Blood

140

650

2.21

16.63

4.4

6.1

0.9

0.28

132

608

(3022948) Iron [Moles/volume] in Serum or Plasma

482

3270

1.56

16.54

2.1

2.3

umol/l

14.3

14.5

0.12

444

3040

(3047181) Lactate [Moles/volume] in Blood

124

550

2.31

16.43

4.4

7.0

mmol/l

1.2

0.20

110

482

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

147

701

2.15

16.34

1.6

1.7

titre

125.0

263.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

444

2969

1.58

16.21

2.1

2.2

g/l

2.5

2.4

1.16

408

2752

(3024980) IgG subclass 4 [Mass/volume] in Serum

401

2.52

16.03

1.5

1.7

g/l

0.6

0.7

0.44

313

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

272

1613

1.75

15.82

3.4

3.2

mmol/l

1.2

1.00

247

1391

(3002032) Base excess in Venous blood by calculation

263

1547

1.76

15.73

5.1

3.7

mmol/l

2.1

1.8

0.72

213

1252

(3027135) IgG subclass 1 [Mass/volume] in Serum

246

2.93

15.55

1.5

1.4

g/l

6.2

6.6

0.32

178

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2581

23814

1.50

15.44

11.8

9.1

ml/min/173m2

91.9

90.7

2.53

2224

19440

(21494814) CD8 cells/100 lymphocytes in Specimen

100

4.14

15.35

1.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

300

1849

1.69

15.16

4.7

4.3

0.1

0.2

0.37

452

(3028192) IgG subclass 2 [Mass/volume] in Serum

245

2.90

15.07

1.5

1.4

g/l

2.8

2.9

0.13

176

(3024139) IgG subclass 3 [Mass/volume] in Serum

245

2.90

15.07

1.5

1.4

g/l

0.4

0.19

175

(4062490)

245

2.90

15.07

1.5

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

233

1347

1.79

14.78

1.7

1.6

—

(36660697) Celiac disease serology panel - Serum

369

2413

1.60

14.75

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

379

2496

1.59

14.70

1.2

iu/ml

107.9

163.6

2.53

156

988

(3005322) IgE [Units/volume] in Serum or Plasma

320

2022

1.65

14.69

1.3

u/ml

216.5

187.7

0.15

295

1890

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

149

745

2.05

14.64

5.3

2.7

0.7

0.96

142

716

(3042936) Bacteria identified in Isolate by Culture

438

2991

1.54

14.48

2.2

1.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

5.22

14.37

1.3

nmol/l

145.0

141.0

0.03

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

121

563

2.20

14.33

2.1

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

310

1956

1.65

14.30

3.2

3.4

pmol/l

4.5

4.6

0.56

279

1760

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

143

3.47

14.26

1.4

u/l

5.1

6.1

0.71

119

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

464

3224

1.52

14.13

3.1

2.6

e6/l

3.2

3.7

0.54

254

1642

(3017446) Testosterone [Moles/volume] in Serum or Plasma

235

1380

1.76

14.13

2.4

2.1

nmol/l

11.8

11.7

0.10

211

1230

(3000060) B lymphocytes [#/volume] in Blood

4.36

14.04

2.2

2.1

e6/l

57.5

171.9

2.85

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

372

2.46

14.00

1.2

1.3

—

34.3

—

(3002385) Erythrocyte distribution width [Ratio]

2466

22665

1.43

14.00

16.9

12.8

13.4

13.5

3.20

2437

22201

(3033658) Prothrombin time (PT) actual/Normal

741

5646

1.41

13.93

3.6

3.5

97.2

96.4

0.40

718

5482

(4010399)

256

1550

1.71

13.80

1.4

—

(3008898) HLA-B27 [Presence]

230

1352

1.76

13.78

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

553

4004

1.46

13.70

1.7

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

212

2.92

13.34

1.1

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

306

1960

1.62

13.28

3.1

4.2

u/l

218.5

238.0

2.21

291

1877

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

333

2.50

13.26

1.3

1.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

248

1508

1.70

13.16

6.5

7.2

mmol/l

1.2

1.3

0.50

238

1447

(3022145) Colonoscopy Study observation

382

2589

1.54

13.00

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

118

3.59

12.96

1.2

1.5

nmol/l

138.1

135.1

0.16

118

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

165

893

1.90

12.94

1.1

u/ml

3.3

4.5

0.19

141

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

393

2687

1.53

12.84

2.2

2.4

24.1

24.2

0.05

331

2321

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

109

509

2.18

12.83

3.3

3.9

57.2

56.6

0.21

109

509

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

4.94

12.62

1.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

277

2.60

12.49

1.6

1.5

—

(3025941) Bacteria identified in Stool by Culture

263

1663

1.64

12.01

1.3

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

352

2384

1.54

11.99

4.3

5.6

mmol/l

1.0

0.17

335

2245

(3048929) Epstein Barr virus Ab [Presence] in Serum

191

1109

1.77

11.95

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

203

1201

1.74

11.90

1.5

1.3

—

(40758558) Short blood count panel - Blood

777

6125

1.36

11.55

6.2

6.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

185

1075

1.77

11.55

1.4

1.3

u/l

11.8

10.1

0.81

157

895

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

185

2.90

11.54

3.1

2.7

e6/l

938.5

783.7

0.74

(3023323) Follitropin [Units/volume] in Serum or Plasma

348

2373

1.53

11.47

1.5

1.3

iu/l

26.9

26.0

0.19

310

2047

(3039000) Anion gap in Blood

367

2.30

11.18

5.1

8.9

mmol/l

10.8

11.5

1.06

331

(3018572) Chloride [Moles/volume] in Blood

368

2.29

11.11

5.1

8.9

mmol/l

105.8

105.7

0.08

332

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

147

3.09

11.01

2.7

46.6

45.4

0.12

(3024731) MCV [Entitic volume]

3042

29618

2.45

10.93

22.6

15.6

90.2

0.28

3029

29323

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

197

1185

1.71

10.89

1.5

—

(3035941) MCH [Entitic mass]

3042

29621

2.44

10.87

22.6

15.6

30.1

0.75

3029

29324

(3022217) INR in Platelet poor plasma by Coagulation assay

283

1865

1.57

10.87

17.1

15.3

inr

1.2

0.03

291

(3007461) Platelets [#/volume] in Blood

3040

29596

2.40

10.82

22.7

15.7

e9/l

264.1

263.1

0.44

3014

29009

(3026361) Erythrocytes [#/volume] in Blood

3042

29625

2.43

10.80

22.7

15.6

e12/l

4.5

0.31

3010

28989

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

299

2000

1.55

10.75

3.5

2.7

—

(3010813) Leukocytes [#/volume] in Blood

3042

29632

2.42

10.66

22.7

15.7

e9/l

6.6

6.7

1.90

3009

28983

(3000963) Hemoglobin [Mass/volume] in Blood

3042

29634

2.42

10.63

22.8

15.7

g/l

135.8

135.6

0.31

3029

29328

(46235355) HIV 1 and 2 tests - Meaningful Use set

956

7850

1.31

10.59

2.1

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

403

2878

1.46

10.56

2.2

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2341

21647

1.33

10.36

4.2

3.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

671

5248

1.36

10.34

2.2

2.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

136

745

1.86

10.33

1.5

1.3

u/ml

3.8

6.5

0.63

117

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

134

733

1.87

10.22

1.5

1.3

u/ml

3.4

0.01

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

265

1746

1.57

10.19

2.2

ml/min/173m2

79.8

75.7

1.08

104

655

(3026493) Urate [Moles/volume] in Serum or Plasma

719

5695

1.34

10.17

2.2

umol/l

2037.7

3397.9

0.76

642

5080

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

7.81

10.14

1.1

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

134

3.09

10.05

2.7

2.9

u/ml

574.0

821.0

0.77

134

(3000570) Elastase.pancreatic [Mass/mass] in Stool

111

574

1.97

10.02

1.5

1.3

ug/g

334.0

308.0

0.52

286

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

153

880

1.78

9.92

6.6

10.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.58

9.92

1.0

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

196

2.68

9.86

1.2

ratio

1.0

0.03

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

350

2.23

9.76

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.79

9.76

1.7

1.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

131

724

1.85

9.69

1.5

1.4

u/l

19.0

23.4

1.04

111

609

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

157

922

1.74

9.49

1.5

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

185

1138

1.67

9.43

2.3

2.6

ng/l

91.1

131.8

0.86

162

1014

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

173

1051

1.68

9.25

3.0

3.2

mmol/l

1.3

1.6

0.45

121

782

(3009343) pH of Capillary blood

176

1082

1.66

9.00

3.1

3.2

7.4

0.27

140

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.28

8.99

1.1

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

234

1543

1.56

8.97

1.2

1.1

titre

104.0

123.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

177

1093

1.66

8.90

3.0

3.2

kpa

5.1

5.2

0.08

170

1031

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.61

8.83

3.4

3.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

214

2.50

8.79

1.3

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

729

5893

1.31

8.77

2.3

2.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.40

8.61

1.7

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

310

2.22

8.60

1.3

nmol/l

0.1

0.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

105

566

1.89

8.44

1.4

1.2

u/ml

2.4

3.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

244

1653

1.52

8.28

1.6

mu/l

327.7

295.4

0.48

219

1478

(3012501) Base excess in Blood by calculation

416

2.02

8.24

3.6

3.3

mmol/l

2.2

2.4

0.44

262

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

303

2.20

8.23

1.4

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

489

3766

1.35

8.17

1.6

1.8

1.4

0.07

432

3402

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

112

629

1.81

7.93

1.1

1.2

—

(40761536) Microorganisms panel - Urine sediment

310

2226

1.44

7.84

5.1

3.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

467

1.93

7.78

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

163

1022

1.63

7.75

2.0

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

896

7542

1.26

7.68

2.3

2.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

352

2.07

7.67

1.5

1.3

u/ml

9.8

38.3

—

(3011985) Renin [Units/volume] in Plasma

295

2.16

7.51

1.8

1.6

mu/l

38.5

48.7

0.39

265

(3017732) Neutrophils [#/volume] in Blood

261

1837

1.46

7.35

2.1

2.4

e9/l

4.1

0.17

221

1553

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

470

1.90

7.32

1.5

1.6

—

(3010421) pH of Blood

499

1.87

7.30

3.5

3.4

7.4

0.33

412

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

778

6472

1.27

7.30

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.15

7.27

2.3

1.1

—

(4034850)

126

754

1.70

7.19

8.1

7.4

—

(3008295) Osmolality of Serum or Plasma

198

2.39

7.18

1.4

1.5

mosm/kgh2o

288.2

282.8

1.30

153

(3036489) Thrombin time

148

928

1.62

7.06

2.0

22.4

21.1

0.59

111

784

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

103

587

1.78

6.99

2.1

2.0

ug/l

0.6

1.9

1.60

532

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

179

1178

1.55

6.97

1.1

u/ml

1.1

3.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

104

596

1.77

6.93

1.2

u/ml

225.6

262.5

0.87

386

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

465

1.87

6.91

2.4

5.7

iu/ml

1820.6

609.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

471

3695

1.32

6.89

2.4

1.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

123

742

1.68

6.83

1.3

1.5

nmol/l

0.4

0.5

0.20

102

606

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.11

6.81

1.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

126

766

1.67

6.80

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

104

2.90

6.73

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

105

2.88

6.63

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

124

760

1.66

6.50

1.2

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

280

2.09

6.45

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

528

1.78

6.42

2.2

2.0

g/l

2.8

3.1

2.94

430

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

551

1.77

6.39

2.2

2.0

g/l

6.9

7.4

1.59

445

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

463

1.84

6.39

1.2

u/ml

11.2

3.8

0.63

149

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

6.69

6.31

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

211

2.25

6.26

2.6

2.8

—

(1616796) Gas panel - Central venous blood

395

1.89

6.22

3.6

2.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

251

2.13

6.20

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

564

1.74

6.18

2.2

2.5

ug/l

264.0

427.3

0.61

518

(3024522) Salmonella sp identified in Specimen by Organism specific culture

272

2.08

6.14

1.6

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

506

1.78

6.13

2.3

2.1

g/l

10.3

10.6

0.21

449

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

551

1.75

6.11

2.2

2.0

g/l

3.8

0.08

418

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

122

758

1.63

6.09

1.2

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

260

2.10

6.07

1.4

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

561

1.73

6.02

1.8

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

480

1.79

6.00

2.3

2.2

g/l

1.0

0.7

0.33

442

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

372

1.90

5.98

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

372

1.90

5.98

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

275

2.06

5.98

1.6

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2535

24171

1.27

5.97

3.6

3.3

mmol/l

1.3

0.08

2393

22858

(3045424) Erythrocytes [Presence] in Urine

402

1.86

5.92

1.4

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

270

2.06

5.88

1.6

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

551

1.73

5.85

2.2

2.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.02

5.74

1.1

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.02

5.74

1.1

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

487

1.77

5.73

1.4

1.3

—

(3045414) Leukocytes [Presence] in Urine

163

1100

1.51

5.70

1.6

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

400

1.84

5.69

2.5

3.0

mmol/l

23.8

24.7

1.33

366

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

281

2.01

5.66

1.5

1.4

pmol/l

323.6

323.8

0.00

223

(3019225) pH of Specimen

258

1903

1.39

5.63

3.6

3.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

5.90

5.62

1.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

269

2.03

5.57

1.6

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

249

1829

1.39

5.57

2.2

2.7

1.6

1.7

1.17

228

1641

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

470

1.76

5.53

2.6

2.9

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

270

2.02

5.52

1.6

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

4.81

5.49

1.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

145

963

1.53

5.48

1.6

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

271

2.01

5.47

1.6

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

450

1.78

5.45

1.3

—

(3000991) Gas panel - Venous blood

203

1445

1.43

5.43

8.5

—

(3009508) Creatinine [Moles/volume] in Urine

724

6152

1.23

5.42

3.3

mmol/l

7.7

7.9

0.47

624

5333

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.03

5.37

1.0

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.03

5.37

1.0

1.1

92.7

93.4

0.05

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

366

1.85

5.30

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

194

2.18

5.28

1.9

2.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

196

1397

1.43

5.22

2.6

3.8

ng/l

60.1

75.8

5.63

176

1257

(3023520) Reticulocytes [#/volume] in Blood

184

1297

1.45

5.20

2.0

2.7

e9/l

69.7

72.3

0.41

140

942

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

342

2667

1.32

5.19

2.3

2.7

umol/l

6.1

6.6

0.25

290

2287

(3051387) C reactive protein [Mass/volume] in Capillary blood

450

1.75

5.17

4.2

3.1

mg/l

24.3

22.6

0.15

280

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

207

1494

1.41

5.14

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

134

2.40

5.05

1.4

1.5

nmol/l

2.5

2.9

0.11

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.28

5.04

1.9

1.7

mg/l

1.1

3.7

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.28

5.04

1.9

1.7

mg/l

0.8

2.4

—

(40768804) Tissue Pathology biopsy report

1177

10535

1.19

5.03

2.1

1.9

—

(40767503) Oxygen content in Capillary blood by calculation

368

1.81

4.92

2.8

2.2

18.0

16.7

2.31

179

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

160

1113

1.46

4.87

7.6

7.4

mmol/l

25.0

24.8

0.31

160

1108

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

211

1550

1.39

4.75

2.1

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

776

6719

1.21

4.73

1.6

1.5

—

(3000494) Fungus identified in Specimen by Culture

360

2863

1.29

4.73

1.5

1.4

—

(3011288) Drugs identified in Urine by Screen method

168

1189

1.44

4.68

3.5

3.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.85

4.65

1.0

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2643

25488

1.25

4.61

4.3

3.9

mmol/l

2.9

0.01

2489

24082

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

318

1.84

4.59

1.8

1.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.77

4.53

1.9

1.7

mg/l

1.3

0.9

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

438

1.71

4.53

2.1

2.0

g/l

40.2

38.3

2.06

396

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

438

1.71

4.53

2.1

2.0

g/l

0.0

0.05

416

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

194

2.08

4.50

1.4

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

121

809

1.52

4.49

2.0

1.9

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.42

4.46

1.1

umol/24h

0.6

0.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2619

25252

1.24

4.45

4.0

3.6

mmol/l

4.8

0.52

2479

24004

(3022313) Gas panel - Capillary blood

120

803

1.51

4.44

3.2

3.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

331

1.80

4.35

1.5

1.7

—

(3021901) Oxygen saturation in Capillary blood

281

1.87

4.32

2.4

2.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

2.63

4.22

1.5

u/l

10.9

12.8

0.75

(43055514) Macroprolactin [Presence] in Serum or Plasma

108

2.42

4.22

1.3

1.5

—

(3037121) Protein [Mass/volume] in Urine

107

708

1.53

4.19

3.6

3.3

g/l

0.2

0.3

0.91

309

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

399

3266

1.25

4.15

4.3

3.8

ug/l

1.9

2.2

0.28

367

2978

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

231

1761

1.34

4.14

1.1

1.0

—

(3049717) Cytology report of Urine Cyto stain

465

1.65

4.14

2.3

—

(3000492) Spirometry study

336

2697

1.28

4.12

1.5

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

108

720

1.52

4.10

1.2

1.3

titre

442.5

125.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2604

25145

1.22

4.04

3.9

3.6

mmol/l

1.5

0.61

2461

23827

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

175

1283

1.39

4.03

2.1

2.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

539

1.59

4.02

1.2

1.1

au/ml

10.3

12.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

196

2.00

4.02

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

209

1578

1.35

4.00

2.5

2.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

366

1.71

3.88

1.5

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

112

762

1.49

3.87

4.0

2.6

g/l

3.2

3.6

2.49

104

720

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

220

1.92

3.87

1.3

u/ml

2.2

0.6

0.65

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

145

2.15

3.86

1.0

1.1

88.8

91.5

0.22

112

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

127

2.22

3.76

1.2

g/l

0.3

1.16

100

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

152

1102

1.40

3.76

1.6

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

573

1.55

3.74

1.1

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

326

1.73

3.70

1.1

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

231

1.87

3.69

1.4

1.7

59.0

55.7

0.19

151

(3013139) Helicobacter pylori Ag [Presence] in Stool

229

1777

1.31

3.66

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

140

1007

1.41

3.63

2.3

—

(3012516) Albumin [Mass/volume] in Urine

592

5117

1.19

3.59

3.1

3.3

mg/l

1502.3

283.0

2.20

330

3246

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

170

2.01

3.59

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

170

2.01

3.59

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

170

2.01

3.59

1.4

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

178

1336

1.35

3.57

2.6

2.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

406

1.64

3.57

2.3

2.1

g/l

0.0

0.00

386

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

164

2.02

3.54

1.2

1.1

u/ml

6.6

33.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

645

5625

1.19

3.54

2.3

2.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

583

5040

1.19

3.53

1.8

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

118

828

1.44

3.52

2.2

2.1

96.7

93.7

0.79

761

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

408

1.63

3.51

2.3

2.1

g/l

0.0

0.49

387

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

138

2.11

3.49

1.5

2.1

u/field

1.5

2.1

0.39

(3021879) Hepatitis B virus core Ab [Presence] in Serum

321

2616

1.25

3.48

1.5

—

(40768443) Skin Pathology biopsy report

129

922

1.42

3.48

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

106

735

1.46

3.38

3.5

3.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

110

769

1.45

3.36

2.6

2.3

160.5

169.8

0.69

102

727

(3028300) Cannabinoids [Presence] in Urine

221

1728

1.30

3.36

2.4

2.2

—

(3037756) Immunofixation for Serum or Plasma

261

1.77

3.35

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

219

1712

1.30

3.33

2.4

2.2

—

(3022621) pH of Urine by Test strip

201

1553

1.31

3.33

2.7

2.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

432

3651

1.21

3.33

1.8

1.9

—

(3027008) Opiates [Presence] in Urine

220

1723

1.30

3.31

2.4

2.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

104

723

1.45

3.28

1.9

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

234

1.81

3.25

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

324

1.68

3.24

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

395

1.61

3.19

2.3

2.2

g/l

137.2

131.3

1.41

297

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

316

2599

1.24

3.18

3.9

3.3

21.4

21.5

0.02

125

981

(3003181) Sodium [Moles/volume] in Urine

236

1.79

3.17

1.2

1.5

mmol/l

85.5

66.4

1.45

201

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

103

720

1.45

3.17

3.4

3.2

mmol/l

24.8

0.09

677

(3027944) Amphetamines [Presence] in Urine

216

1699

1.29

3.15

2.3

2.2

—

(44790047)

237

1.78

3.13

1.5

—

(44790049)

237

1.78

3.13

1.5

—

(44790048)

237

1.78

3.13

1.5

—

(44806118)

237

1.78

3.13

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.51

3.11

1.1

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

105

2.20

3.09

1.4

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

495

1.53

3.07

1.2

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

189

1469

1.31

3.03

5.0

7.8

mmol/l

6.4

7.7

3.11

180

1417

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

106

2.18

3.02

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

457

1.54

3.01

1.2

1.3

u/ml

5.7

3.9

0.29

185

(3020682) Albumin/Creatinine [Ratio] in Urine

610

5364

1.17

3.00

3.8

4.1

mg/mmol

5.6

9.6

2.29

347

3464

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

605

1.47

2.97

1.5

1.8

—

(4306422)

467

1.53

2.96

1.3

1.2

—

(3004451) EKG impression Narrative

2.55

2.95

1.7

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

341

1.62

2.94

1.4

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

413

1.56

2.91

2.3

2.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

536

1.49

2.86

1.1

1.4

u/ml

92.8

104.6

0.64

117

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

109

2.12

2.84

1.2

1.1

93.3

99.6

0.30

(3028679) Herpes simplex virus Ab [Presence] in Serum

186

1.84

2.83

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.77

2.81

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.45

2.79

2.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

228

1839

1.26

2.75

2.3

g/l

0.2

0.85

216

1734

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

268

2202

1.24

2.75

2.9

2.3

u/l

33.1

60.4

0.69

232

1907

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

168

1305

1.30

2.73

1.9

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.21

2.73

1.5

1.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

5.01

2.72

2.3

4.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

196

1.79

2.71

1.3

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.15

2.70

1.4

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.15

2.70

1.4

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.15

2.70

1.4

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.15

2.70

1.4

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

133

1.96

2.65

1.8

1.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

488

1.49

2.64

1.2

—

(4268621)

312

1.61

2.64

2.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

198

1.78

2.63

1.3

1.2

—

(3021788) Differential panel - Synovial fluid

360

1.57

2.62

1.6

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

141

1.92

2.60

1.6

1.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.67

2.59

1.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

114

2.03

2.56

1.2

1.1

94.2

94.6

0.03

(3020191) Ethanol [Moles/volume] in Serum or Plasma

201

1.75

2.52

2.0

1.6

promille

1.3

0.02

160

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

2.11

2.48

1.2

—

(3028433) Virus identified in Specimen by Culture

2.33

2.48

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.47

2.48

1.1

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

106

782

1.37

2.47

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

185

1477

1.27

2.46

1.4

1.3

miu/ml

198.7

233.8

0.74

773

(40759836) Histone Ab [Presence] in Serum by Immunoblot

218

1.71

2.44

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

218

1.71

2.44

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

218

1.71

2.44

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.14

2.44

1.5

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

103

2.05

2.41

1.0

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

204

1.72

2.41

1.0

1.1

iu/ml

4.3

9.6

1.47

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

266

1.63

2.38

1.4

1.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

220

1.69

2.37

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

220

1.69

2.37

1.2

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

6.26

2.37

1.2

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

601

1.41

2.36

1.2

1.3

—

(3044927) Protein electrophoresis panel - Urine

132

1.90

2.35

1.2

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

124

1610

0.76

2.35

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

221

1.68

2.34

1.2

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

191

1.74

2.33

1.7

2.1

34.0

32.4

1.75

191

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

119

1.94

2.30

3.3

3.0

umol/l

105.6

191.4

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.46

2.27

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.46

2.27

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.46

2.27

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.46

2.27

1.2

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

357

1.52

2.27

2.6

3.0

umol/l

35.3

34.0

0.12

317

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

125

1612

0.77

2.26

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

487

4303

1.16

2.25

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

187

1.72

2.20

2.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

126

1617

0.77

2.20

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

126

1616

0.77

2.19

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.51

2.18

1.1

1.3

pmol/l

411.1

315.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

387

1.48

2.13

3.8

3.3

mg/l

23.5

72.4

1.74

304

(3034274) Bile acid [Moles/volume] in Serum --fasting

666

1.36

2.10

2.0

2.2

umol/l

4.7

4.8

0.06

494

(4094501)

530

1.41

2.10

1.1

—

(3036603) Volume of Urine

145

1.80

2.10

1.7

1.4

1578.6

2152.6

—

(3051593) INR in Capillary blood by Coagulation assay

2.71

2.10

1.0

12.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.71

2.10

2.0

2.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

139

1750

0.78

2.10

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

448

1.44

2.06

1.0

1.1

126.6

117.8

1.93

406

(3028717) Thiamine [Mass/volume] in Blood

3.08

2.01

1.3

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

376

1.47

2.01

3.7

3.2

ratio

1.1

1.8

—

(3030313) Adrenal Ab [Titer] in Serum

2.64

2.01

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

209

1.63

1.97

1.6

1.8

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

194

1.66

1.96

1.2

—

20.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

105

1356

0.77

1.96

1.4

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

487

1.41

1.95

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

387

1.46

1.95

3.8

3.3

mg/l

29.1

38.4

0.46

306

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

127

1.82

1.93

2.2

2.9

au/ml

169.5

45.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

463

1.41

1.93

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

102

782

1.31

1.91

1.9

2.1

iu/l

2.7

4.4

4.20

311

(3000475) Leukocytes [#/volume] in Synovial fluid

447

1.42

1.91

1.6

1.7

e6/l

18867.9

9478.2

0.55

321

(3052851) Hemolysis interference index of Serum or Plasma

626

1.35

1.91

3.2

2.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

102

1317

0.77

1.91

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.19

1.88

1.3

1.2

ng/l

40.8

116.7

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.09

1.86

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.09

1.86

1.5

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

100

1.91

1.85

1.4

1.7

—

(3005033) Fetal Nuchal fold Thickness US

102

1311

0.77

1.85

1.4

—

(3017569) Oxygen content in Arterial blood

2.13

1.81

3.1

3.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

112

877

1.29

1.81

6.7

3.9

mmol/l

24.4

24.1

0.48

796

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

101

1.89

1.80

1.4

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.35

1.77

2.8

5.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.35

1.77

1.8

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

177

1.64

1.76

2.7

2.5

55.8

55.0

0.07

123

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

506

1.37

1.75

1.1

u/ml

1.5

3.1

1.95

269

(3051651) Icteric interference index of Serum or Plasma

124

1.78

1.75

5.1

3.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.50

1.74

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

162

1333

1.23

1.73

1.8

1.7

mg/l

3.8

4.1

0.09

124

907

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.85

1.71

1.0

—

0.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

292

2539

1.17

1.70

3.8

3.5

32.0

31.8

0.14

221

1859

(3003338) MCHC [Mass/volume]

2427

23689

1.11

1.70

18.6

13.1

g/l

333.3

332.8

2.17

2417

23525

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.06

1.70

1.0

—

(3017704) Immunofixation for Urine

2.06

1.70

1.6

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

660

6056

1.11

1.69

1.7

1.6

mmol/l

1.4

0.52

580

5250

(3009542) Hematocrit [Volume Fraction] of Blood

2599

25468

1.13

1.69

14.6

11.3

40.1

40.2

0.08

2007

20774

(3009466) Valproate [Moles/volume] in Serum or Plasma

349

1.44

1.69

4.6

6.0

umol/l

347.4

380.5

0.89

312

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

433

1.39

1.69

1.3

1.1

iu/ml

15.3

19837.0

0.56

122

(3006922) Hepatitis E virus Ab [Presence] in Serum

203

1.58

1.68

1.1

—

(3017509) Phencyclidine [Presence] in Urine

2.39

1.67

1.6

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.16

1.66

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

119

1.77

1.66

1.5

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

210

1781

1.19

1.66

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

2.58

1.66

1.9

2.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

212

1.56

1.65

1.6

2.0

mg/l

22.8

23.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

539

1.34

1.63

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

105

1.81

1.63

3.2

2.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

294

1.47

1.62

3.5

3.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

510

0.66

1.61

1.0

u/ml

1.6

0.3

—

115

(3044941) Cell count panel - Synovial fluid

303

1.46

1.60

1.5

—

(3042517) Benzodiazepines panel - Urine

2.33

1.60

6.9

2.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.00

1.58

2.2

3.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.70

1.58

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.85

1.56

1.0

1.2

—

(1002224) Polysomnography panel

163

1360

1.21

1.55

1.2

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

137

1.68

1.55

2.8

3.6

mg/l

8.0

7.7

0.10

112

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

176

1.60

1.54

1.4

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

2.86

1.50

3.2

5.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

218

1.52

1.48

1.5

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

202

1.54

1.48

3.6

6.3

mmol/l

6.7

7.0

0.22

174

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.23

1.46

1.1

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

107

860

1.25

1.46

7.7

10.2

mmol/l

24.6

24.3

0.69

101

815

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.50

1.45

1.1

1.2

umol/24h

1.4

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.88

1.44

1.5

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.88

1.44

1.5

1.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

212

1.51

1.43

1.3

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.31

1.43

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

501

1.32

1.40

1.2

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.86

1.40

1.5

1.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

322

1.40

1.38

3.9

4.4

u/ml

162.2

79.1

0.40

(4211845)

119

1.69

1.37

3.1

2.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

722

0.74

1.37

1.0

1.1

u/ml

0.2

1.2

3.16

319

(3032773) Endomysium IgG Ab [Titer] in Serum

281

1.43

1.36

1.1

—

(21494755) Public health laboratory ask at order entry panel

361

4007

0.89

1.35

1.2

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

183

1.53

1.34

4.7

2.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

167

1.56

1.34

1.6

25.3

35.9

0.80

103

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

324

1.39

1.34

1.4

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

200

1.50

1.32

3.2

3.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

193

0.52

1.29

1.5

mmol/l

4.8

5.4

—

187

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.78

1.28

2.4

2.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.78

1.28

4.2

1.6

umol/24h

334.2

326.8

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.78

1.28

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

344

1.37

1.28

1.1

g/l

1.4

1.5

0.34

314

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

131

0.46

1.28

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

285

1.41

1.27

1.4

1.5

mmol/l

13.3

12.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.05

1.26

1.3

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

170

1.53

1.25

2.3

2.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.23

1.24

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.00

1.23

1.3

—

(3047189) Immunofixation for 24 hour Urine

1.91

1.22

2.0

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

170

1460

1.17

1.22

1.6

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

296

1.39

1.22

1.5

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

469

1.31

1.22

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.04

1.22

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

180

1.50

1.20

1.1

1.2

—

(4198724)

164

1.53

1.20

3.4

3.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

164

1.53

1.20

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

148

1.56

1.20

2.6

3.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.31

1.18

1.0

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

714

0.77

1.17

1.1

u/ml

0.8

1.9

1.60

177

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

118

1.61

1.14

7.8

7.6

u/ml

1965.0

118.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

423

1.31

1.11

3.9

3.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.78

1.10

1.3

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

210

1.43

1.08

1.0

1.1

u/l

53.5

63.1

0.46

144

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

177

1.47

1.07

5.5

7.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

253

1.39

1.06

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

714

1.22

1.05

1.7

2.0

g/l

1.4

0.01

631

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

166

1445

1.16

1.04

1.5

—

(3000012) Reticulocyte production index

1.67

1.04

1.3

1.6

—

(3025130) Human papilloma virus identified in Specimen

622

0.77

1.04

1.7

1.8

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.06

1.03

1.0

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

179

1.46

1.02

2.7

2.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

114

1.58

1.02

1.5

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

189

0.58

1.00

1.2

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

139

1.51

1.00

1.3

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

257

1.37

0.98

1.2

—

(4024509)

198

1.42

0.97

2.1

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

165

1.46

0.96

2.0

3.0

—

(44806420)

0.00

0.96

0.0

2.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

319

1.32

0.96

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.22

0.93

2.3

3.8

umol/l

40.2

43.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

437

1.26

0.91

2.4

3.4

u/ml

0.3

0.04

234

(3003888) Timothy IgE Ab [Units/volume] in Serum

764

0.81

0.91

1.0

1.1

u/ml

6.1

6.5

0.10

423

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

244

1.36

0.90

1.1

1.4

titre

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

193

1.40

0.90

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

474

1.25

0.90

1.5

2.5

nmol/l

1.0

0.9

0.59

414

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.07

0.89

1.2

2.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

216

1941

1.12

0.88

2.5

ug/l

0.6

0.7

1.81

124

1090

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.79

0.87

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

572

0.78

0.87

1.0

1.1

u/ml

4.6

3.8

0.13

233

(1617658) Protocol used for examination of sentinel lymph nodes

227

0.66

0.84

1.1

—

(44813793)

223

1.35

0.81

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

172

1.40

0.80

1.0

1.3

—

(3002256) Pathology report gross observation

340

3145

1.09

0.80

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.82

0.79

1.3

2.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.82

0.79

1.0

1.1

—

(3024928) Oxygen saturation in Venous blood

357

1.26

0.78

10.0

3.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

115

1.48

0.76

1.1

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.09

0.74

2.4

1.9

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.09

0.74

1.4

1.2

—

(3000330) Specific gravity of Urine by Test strip

113

987

1.15

0.74

3.4

2.9

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

108

1.48

0.73

1.3

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

326

1.26

0.72

1.0

1.1

104.1

96.5

1.80

307

(3028308) Erythrocytes [#/volume] in Pleural fluid

117

1.46

0.71

1.1

1.4

e6/l

34489.0

81674.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.92

0.70

3.6

8.5

ug/min

21.8

25.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.92

0.70

1.0

2.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.71

0.70

1.4

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.85

0.68

1.0

1.2

—

2.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.64

0.68

1.0

1.6

—

(44806071)

1.67

0.68

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.49

0.66

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.79

0.66

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

614

0.83

0.65

1.1

u/ml

7.7

3.7

0.54

238

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

180

1635

1.11

0.65

2.0

2.6

u/ml

18.3

41.1

5.89

171

1586

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

189

1.33

0.64

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.50

0.63

1.5

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

1.67

0.61

1.4

2.4

mg/l

4.7

3.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.60

0.61

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

318

3396

0.93

0.61

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

191

1.31

0.61

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.60

0.0

1.0

—

26.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.50

0.59

3.0

2.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

151

0.66

0.59

1.4

1.3

—

(40765096) Chromosome analysis panel by Banding

1.54

0.59

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

220

1.28

0.57

1.1

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

837

0.87

0.55

1.1

u/ml

0.6

1.6

2.04

342

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

412

1.19

0.55

2.5

2.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

257

1.25

0.55

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

241

1.25

0.52

1.1

—

(4035726)

169

1837

0.92

0.52

1.3

1.4

—

(40768793) Breast Pathology biopsy report

677

1.14

0.51

1.4

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

325

0.80

0.50

1.4

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

154

1.30

0.48

1.6

1.4

pmol/l

69.0

233.8

—

(3003694) ABO and Rh group [Type] in Blood

866

8402

1.04

0.48

1.8

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

110

0.64

0.48

35.4

36.7

ug/l

7.4

7.3

—

102

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

138

1.31

0.45

1.4

1.8

—

(3001556) Androgen free Index in Serum or Plasma

1.40

0.45

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.41

0.43

2.9

3.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.41

0.43

1.1

1.3

—

(3019174) dRVVT (LA screen)

1.61

0.43

1.4

1.2

—

(3035880) pH of Pleural fluid

1.43

0.42

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.43

0.42

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.43

0.42

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.43

0.42

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

606

0.87

0.42

1.3

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.56

0.42

1.0

1.1

—

(4015189)

1.56

0.42

1.4

3.4

—

(21494434) Karyotype in Bone marrow

140

1.29

0.42

1.2

—

(4212803)

0.00

0.41

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.5

—

22.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.00

0.40

0.0

6.7

—

7.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.2

—

(40768441) Liver Pathology biopsy report

183

0.76

0.40

1.2

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

625

1.12

0.40

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

0.40

0.0

1.3

—

8.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

626

1.12

0.39

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

106

1.32

0.39

1.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

495

0.87

0.38

1.4

mmol/l

6.5

7.0

0.31

350

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

224

1.21

0.38

1.9

3.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

289

3035

0.95

0.38

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

1.33

0.37

1.2

1.3

u/l

445.8

305.1

0.52

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.31

0.37

1.8

2.1

umol/l

11.3

16.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

180

1.22

0.36

1.6

1.5

nmol/l

1.3

1.5

0.23

165

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.65

0.35

1.0

—

4.6

—

(40768795) Lymph node Pathology biopsy report

212

0.80

0.35

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

700

0.90

0.34

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.36

0.34

1.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.33

0.33

1.3

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

133

0.75

0.33

1.1

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

160

1700

0.94

0.32

3.1

4.2

ug/l

7.2

38.3

0.84

115

1291

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.25

0.29

1.0

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

101

1084

0.93

0.28

1.5

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

225

2353

0.95

0.28

1.3

1.4

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.29

0.28

1.3

1.1

—

6.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

140

1.22

0.27

1.4

g/l

38.9

35.0

0.68

125

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.25

0.27

1.7

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

375

1.12

0.27

1.2

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.69

0.26

5.2

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.69

0.26

10.0

5.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

790

1.08

0.26

1.4

pmol/l

52.8

128.0

2.46

775

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.25

0.25

1.0

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.23

0.25

3.3

2.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.20

0.25

1.1

1.2

u/l

17.4

11.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

198

1.16

0.24

1.0

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.73

0.24

1.0

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.73

0.24

1.0

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

527

0.91

0.24

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

227

1.15

0.23

1.5

1.4

g/l

1.0

0.33

227

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

199

1.16

0.23

1.0

1.3

—

250.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.28

0.23

1.2

—

221.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

409

1.10

0.22

1.7

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

200

1.15

0.22

1.7

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

119

1129

1.06

0.21

1.5

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

2.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.2

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

181.7

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

21.3

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

226

2342

0.96

0.21

1.6

1.7

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

1.9

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

8.6

—

148.0

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

1.25

0.20

1.6

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

2.0

—

(3002619) Bacteria identified in Specimen by Culture

1.22

0.20

1.2

—

(3015183) Erythrocyte sedimentation rate

214

1.12

0.17

1.1

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

728

1.06

0.17

1.3

1.2

—

(3011648) Oxygen content in Venous blood

139

1.15

0.16

2.8

3.0

11.4

11.2

0.09

139

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.11

0.16

1.3

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.77

0.15

3.2

2.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

192

0.88

0.14

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

217

1.11

0.14

1.2

1.7

—

(40768446) Kidney Pathology biopsy report

0.82

0.13

1.1

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

132

1.14

0.13

1.3

1.6

—

911277.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

267

1.09

0.13

2.0

1.6

—

(40768806) Pleura Pathology biopsy report

127

0.87

0.12

1.4

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.18

0.12

1.0

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

454

1.06

0.11

1.7

1.6

mmol/l

7.1

7.5

0.69

285

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.14

0.10

1.0

—

8.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.11

0.09

1.2

3.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.11

0.09

1.2

3.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.03

0.08

4.0

1.7

u/l

14.4

57.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

765

0.97

0.08

1.5

1.3

ug/l

4.9

4.1

0.17

710

(3014599) Egg white IgE Ab [Units/volume] in Serum

263

1.07

0.08

1.1

1.0

u/ml

0.4

0.7

0.48

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.79

0.08

1.0

ug/l

79.9

73.3

—

(3012441) Differential panel - Pleural fluid

117

1.11

0.08

1.2

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

154

0.91

0.08

3.0

3.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

254

1.06

0.07

1.1

1.0

u/ml

0.5

2.7

0.90

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.84

0.07

2.3

1.4

ug/l

8.6

8.0

—

(3024932) HLA-DR beta [Type]

0.82

0.07

1.0

1.1

—

(3024471) HLA-A [Type]

1.06

0.07

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

167

1.08

0.06

1.4

e6/l

39398.9

70121.6

—

113

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

109

1.10

0.06

1.0

1.2

—

(1761868) Lipid panel - Serum or Plasma

1086

10813

1.01

0.05

2.4

2.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

208

1.06

0.05

1.3

—

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

596

0.97

0.05

2.7

3.7

u/ml

876.0

427.5

0.23

502

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

179

1.06

0.05

1.6

1.9

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

241

0.95

0.04

1.0

u/ml

0.1

2.7

—

(3014051) Protein [Presence] in Urine by Test strip

547

1.02

0.04

1.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

422

0.97

0.03

2.7

2.6

ug/min

65.9

99.3

0.38

270

(40768800) Prostate Pathology biopsy report

159

0.94

0.03

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

202

2003

1.01

0.03

1.5

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

122

1.07

0.02

1.0

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

143

1.05

0.01

1.5

1.9

—

2.3

—

(3034426) Prothrombin time (PT)

104

1.06

0.01

1.2

1.3

—

(3016750) Collection duration of Urine

106

0.94

0.01

1.5

2.4

min

500.7

509.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

144

1.04

0.00

1.8

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

125

0.96

0.00

1.2

1.3

mmol/l

5.9

6.4

0.28

113

(4146454)

155

0.97

0.00

2.7

2.8

—

(3045788) Cell count panel - Pleural fluid

101

0.99

0.00

1.2

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

745

0.99

0.00

1.7

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

166

1.02

0.00

1.4

1.3

—

(3045142) Bone marrow Pathology biopsy report

196

1.02

0.00

1.3

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

112

0.98

0.00

1.1

1.5

—

(4281824)

258

1.01

0.00

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

193

0.98

0.00

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

1.01

0.00

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.91

0.00

3.3

2.9

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3044007) Cell count panel - Peritoneal fluid

1.02

0.00

1.2

2.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3033799) Differential panel - Peritoneal fluid

1.00

0.00

1.0

2.1

—

(3024263) Appearance of Synovial fluid

0.94

0.00

1.6

2.3

—

(3014271) Vancomycin [Susceptibility]

1.02

0.00

2.2

2.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

120

1.00

0.00

1.1

u/ml

0.3

11.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(4133840)

0.89

0.00

1.3

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

170

1.00

0.00

2.8

3.3

mg/l

135.0

37.1

—

122

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

140.5

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

0.0

2.4

—

2.2

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.5

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.7

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.02

0.00

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_POSTOPNEURO and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_POSTOPNEURO	1.074 [0.92, 1.25]	0.355
Birth year	0.993 [0.98, 1.0]	0.098

During the follow-up period (1.1.1998 — 31.12.2019), 273 out of 10559 females with G6_POSTOPNEURO died.

Males

Parameter	HR [95% CI]	p-value
G6_POSTOPNEURO	1.037 [0.9, 1.2]	0.615
Birth year	0.99 [0.98, 1.0]	0.029

During the follow-up period (1.1.1998 — 31.12.2019), 240 out of 4412 males with G6_POSTOPNEURO died.

Mortality risk

Mortality risk for people of age

years, who have G6_POSTOPNEURO.

N-year risk	Females	Males
1	0.117%	0.219%
5	0.627%	1.243%
10	1.585%	3.256%
15	2.824%	6.215%
20	4.87%	10.678%

Relationships between endpoints

↥

Index endpoint: G6_POSTOPNEURO – Postprocedural disorders of nervous system

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Postprocedural disorders of nervous system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints